<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id><journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id><journal-title-group><journal-title>Frontiers in Neuroscience</journal-title></journal-title-group><issn pub-type="ppub">1662-4548</issn><issn pub-type="epub">1662-453X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6041410</article-id><article-id pub-id-type="doi">10.3389/fnins.2018.00464</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>An Overview of the Role of Lipofuscin in Age-Related Neurodegeneration </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Moreno-García</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>†</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kun</surname><given-names>Alejandra</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>†</sup></xref></contrib><contrib contrib-type="author"><name><surname>Calero</surname><given-names>Olga</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>†</sup></xref></contrib><contrib contrib-type="author"><name><surname>Medina</surname><given-names>Miguel</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/31407/overview"/></contrib><contrib contrib-type="author"><name><surname>Calero</surname><given-names>Miguel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="corresp" rid="c002"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/219213/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Chronic Disease Programme-CROSADIS, Instituto de Salud Carlos III</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country></aff><aff id="aff2"><sup>2</sup><institution>Biochemistry Section, Science School, Universidad de la República</institution>, <addr-line>Montevideo</addr-line>, <country>Uruguay</country></aff><aff id="aff3"><sup>3</sup><institution>Protein and Nucleic Acids Department, Instituto de Investigaciones Biológicas Clemente Estable</institution>, <addr-line>Montevideo</addr-line>, <country>Uruguay</country></aff><aff id="aff4"><sup>4</sup><institution>Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country></aff><aff id="aff5"><sup>5</sup><institution>Alzheimer Disease Research Unit, CIEN Foundation, Queen Sofia Foundation Alzheimer Center</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country></aff><author-notes><fn fn-type="edited-by"><p><text><SENT sid="1" pm="."><plain>Edited by: Naruhiko Sahara, National Institute of Radiological Sciences (NIRS), Japan </plain></SENT>
</text></p></fn><fn fn-type="edited-by"><p><text><SENT sid="2" pm="."><plain>Reviewed by: Tomohiro Miyasaka, Doshisha University, Japan; Sandra Tenreiro, CEDOC-Chronic Diseases Research Center, NMS-UNL, Portugal </plain></SENT>
</text></p></fn><corresp id="c001">*Correspondence: Miguel Medina <email>mmedina@ciberned.es</email></corresp><corresp id="c002">Miguel Calero <email>mcalero@isciii.es</email></corresp><fn fn-type="other" id="fn001"><p><text><SENT sid="3" pm="."><plain>This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience </plain></SENT>
</text></p></fn><fn fn-type="other" id="fn002"><p><text><SENT sid="4" pm="."><plain>†These authors have contributed equally to this work. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="epub"><day>05</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>12</volume><elocation-id>464</elocation-id><history><date date-type="received"><day>18</day><month>1</month><year>2018</year></date><date date-type="accepted"><day>18</day><month>6</month><year>2018</year></date></history><permissions><copyright-statement>Copyright © 2018 Moreno-García, Kun, Calero, Medina and Calero.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Moreno-García, Kun, Calero, Medina and Calero</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="5" pm="."><plain>Despite aging being by far the greatest risk factor for highly prevalent neurodegenerative disorders, the molecular underpinnings of age-related brain changes are still not well understood, particularly the transition from normal healthy brain aging to neuropathological aging. </plain></SENT>
<SENT sid="6" pm="."><plain>Aging is an extremely complex, multifactorial process involving the simultaneous interplay of several processes operating at many levels of the functional organization. </plain></SENT>
<SENT sid="7" pm="."><plain>The buildup of potentially toxic protein aggregates and their spreading through various brain regions has been identified as a major contributor to these pathologies. </plain></SENT>
<SENT sid="8" pm="."><plain>One of the most striking morphologic changes in neurons during normal aging is the accumulation of lipofuscin (LF) aggregates, as well as, neuromelanin pigments. </plain></SENT>
<SENT sid="9" pm="."><plain>LF is an autofluorescent lipopigment formed by lipids, metals and misfolded proteins, which is especially abundant in nerve cells, cardiac muscle cells and skin. </plain></SENT>
<SENT sid="10" pm="."><plain>Within the Central Nervous System (CNS), LF accumulates as aggregates, delineating a specific senescence pattern in both physiological and pathological states, altering neuronal cytoskeleton and cellular trafficking and metabolism, and being associated with neuronal loss, and glial proliferation and activation. </plain></SENT>
<SENT sid="11" pm="."><plain>Traditionally, the accumulation of LF in the CNS has been considered a secondary consequence of the aging process, being a mere bystander of the pathological buildup associated with different neurodegenerative disorders. </plain></SENT>
<SENT sid="12" pm="."><plain>Here, we discuss recent evidence suggesting the possibility that LF aggregates may have an active role in neurodegeneration. </plain></SENT>
<SENT sid="13" pm="."><plain>We argue that LF is a relevant effector of aging that represents a risk factor or driver for neurodegenerative disorders. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>aging</kwd><kwd>amyloid</kwd><kwd>autofluorescence</kwd><kwd>lipofuscin</kwd><kwd>neurodegeneration</kwd><kwd>oxidative stress</kwd><kwd>protein deposits</kwd></kwd-group></SecTag><funding-group><award-group><funding-source id="cn001">Ministerio de Economía y Competitividad<named-content content-type="fundref-id">10.13039/501100003329</named-content></funding-source><award-id rid="cn001">SAF2016-78603</award-id></award-group><award-group><funding-source id="cn002">National Programme for the Promotion of Talent and its Employability</funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="0"/><equation-count count="0"/><ref-count count="148"/><page-count count="13"/><word-count count="11846"/></counts></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro" id="s1"><title><text><SENT sid="14" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="15" pm="."><plain>Despite aging being by far the greatest risk factor for highly prevalent neurodegenerative disorders, the molecular underpinning of age-related brain changes is still not well understood (Kukull et al., 2002). </plain></SENT>
<SENT sid="16" pm="."><plain>Physiological changes associated with aging are inherent to all animals, representing an extremely complex and multifactorial process involving the simultaneous interplay of several processes operating at many levels of the functional organization. </plain></SENT>
</text></p><p><text><SENT sid="17" pm="."><plain>Recently, it has been proposed a classification of the main cellular and molecular events affected by aging, and particularly by brain aging (López-Otín et al., 2013). </plain></SENT>
<SENT sid="18" pm="."><plain>For any factor to be considered a hallmark of aging, it should meet the following criteria: (I) it should be present during normal aging; (II) its exacerbation should trigger an accelerated aging; and (III) its amelioration should prevent the normal aging course, even extending lifespan. </plain></SENT>
<SENT sid="19" pm="."><plain>Accordingly, one of the most relevant features of aging is related to the increasingly dysfunctional mechanisms of renewal of cellular constituents that precludes the clearance of damaged biomolecules and organelles and its replacement by new functional structures. </plain></SENT>
<SENT sid="20" pm="."><plain>This sustained inefficient recycling mechanism leads to the accumulation of unfit molecules that further interfere with cellular functions, preferentially within long-lived post-mitotic cells such as neurons (Hung et al., 2010; López-Otín et al., 2013). </plain></SENT>
<SENT sid="21" pm="."><plain>Among the main components of this biological “garbage,” we could find indigestible protein aggregates, defective mitochondria and lipofuscin (LF) (Terman, 2001). </plain></SENT>
</text></p><p><text><SENT sid="22" pm="."><plain>LF is a post-mitotic pigment traditionally associated with aging (“age pigment”) (Terman and Brunk, 1998). </plain></SENT>
<SENT sid="23" pm="."><plain>In this review, we discuss recent evidence that suggests the possibility that rather than being a mere bystander of the aging process, LF may have an active role in neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), age-related macular degeneration (AMD). </plain></SENT>
</text></p></sec></SecTag><sec id="s2"><title><text><SENT sid="24" pm="."><plain>Lipofuscin composition and distribution </plain></SENT>
</text></title><p><text><SENT sid="25" pm="."><plain>LF is a fluorescent complex mixture composed of highly oxidized cross-linked macromolecules (proteins, lipids, and sugars) with multiple metabolic origins (Höhn et al., 2010; König et al., 2017; Rodolfo et al., 2018). </plain></SENT>
<SENT sid="26" pm="."><plain>The nature and structure of LF complexes seem to vary among tissues and show temporal heterogeneity in composition of oxidized proteins (30–70%), lipids (20–50%), metals cations (Fe3+, Fe2+, Cu2+, Zn2+, Al3+, Mn2+, Ca2+) (2%), and sugar residues (Benavides et al., 2002; Double et al., 2008). </plain></SENT>
</text></p><p><text><SENT sid="27" pm="."><plain>Because of its polymeric and highly cross-linked nature, LF cannot be degraded, nor cleared by exocytosis, thus being accumulated within the lysosomes and cell cytoplasm of long-lived post-mitotic and senescent animal cells. </plain></SENT>
<SENT sid="28" pm="."><plain>Opposite, proliferative cells efficiently dilute LF aggregates during cell division, showing low or no accumulation of the pigment (Brunk and Terman, 2002; Porta, 2002; Terman and Brunk, 2005; Rodgers et al., 2009; Firlag et al., 2013). </plain></SENT>
<SENT sid="29" pm="."><plain>For this reason, LF deposits are especially abundant in nerve cells, cardiac muscle cells, and skin. </plain></SENT>
</text></p><p><text><SENT sid="30" pm="."><plain>LF fluorescence shows a large heterogeneity in the emission spectra, which reveals differences in its chemical composition, as a result of its ripening in specific metabolic pathways (Schwartsburd, 1995). </plain></SENT>
<SENT sid="31" pm="."><plain>In general, the LF fluorescence emission presents a very wide spectra ranging from 400 to 700 nm, with a maximum around of 578 nm for excitation at 364 nm (Warburton et al., 2007). </plain></SENT>
<SENT sid="32" pm="."><plain>Due to its elevated levels within brain tissue, LF fluorescence interferes with different analytical techniques such as immunoconfocal microscopy. </plain></SENT>
<SENT sid="33" pm="."><plain>Thus, different experimental protocols have been used to block LF autofluorescence in tissue samples, such as Sudan Black, copper sulfate or picric acid treatments. </plain></SENT>
<SENT sid="34" pm="."><plain>However, these methods do not allow the study of LF concurrently with neurodegeneration markers, thus impeding the analysis of LF contribution to pathology. </plain></SENT>
</text></p><p><text><SENT sid="35" pm="."><plain>Additionally, as LF plays a clear role in cellular senescence, and increasing interest is focused on the study of its potential pathophysiological role, several methods have been developed to quantify LF in brain tissue. </plain></SENT>
<SENT sid="36" pm="."><plain>Based on its high lipid content, classical methods of isolation and quantitation of LF employed organic solvent extraction or density gradient ultracentrifugation protocols (Siakotos, 1974; Taubold et al., 1975; Ottis et al., 2012). </plain></SENT>
<SENT sid="37" pm="."><plain>However, due to its fluorescent properties, most recent methods for LF detection and quantification are based on the use of fluorescence microscopy (Moore et al., 1995; Jung et al., 2010; Zheng et al., 2010; Jensen et al., 2016). </plain></SENT>
<SENT sid="38" pm="."><plain>Provided that LF presents a very broad fluorescence spectrum, fluorescence images of tissue preparations can be acquired over a broad range of wavelengths. </plain></SENT>
<SENT sid="39" pm="."><plain>Depending on the need to colocalized LF autofluorescence with other cellular structures, non-overlapping anti-antibodies or probes should be selected (Jung et al., 2010). </plain></SENT>
<SENT sid="40" pm="."><plain>For example, DNA probes emitting in the far-red range can be combined with the detection of LF in both green and red channels (Zheng et al., 2010). </plain></SENT>
<SENT sid="41" pm="."><plain>Recently, we have developed a method based on channel filtering of confocal microscopy to identify and discriminate LF autofluorescence signals from the specific ones, such as amyloid plaques in the AD brain (see Figure 1) (Kun et al., 2018). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F1" position="float"><label>Figure 1</label><caption><p><text><SENT sid="42" pm="."><plain>Confocal fluorescence microscopy analysis of AD brain tissue. </plain></SENT>
<SENT sid="43" pm="."><plain>The characteristic perinuclear lipofuscin deposits can be clearly identified in brain tissue by autofluorescent emission at 510–530 nm (A, green) and at 570–600 nm (B, red), with excitation at 488 nm and 561 nm, respectively. </plain></SENT>
<SENT sid="44" pm="."><plain>Additionally, amyloid beta plaques (C, white) were immunostained by the specific monoclonal antibody 4G8 (Covance) followed by an anti-antibody conjugated to a fluorophore excitable to 633 nm and emitting light from 670 to 700 nm (Invitrogen GAM-A-21052). </plain></SENT>
<SENT sid="45" pm="."><plain>DNA in nuclear domains was identified by DAPI probe (D, blue). </plain></SENT>
<SENT sid="46" pm="."><plain>In the merged image (E), lipofuscin aggregates (pink-orange) appears widely distributed throughout the tissue with incidental colocalization within the amyloid beta plaques. </plain></SENT>
<SENT sid="47" pm="."><plain>Images represent a single confocal plane of cryosections of prefrontal cortex from an AD patient treated with 70% formic acid for 10 s. The yellow arrows indicate LF aggregates that are located within senile plaques. </plain></SENT>
<SENT sid="49" pm="."><plain>Adapted with permission from chapter 31 “Characterization of Amyloid-β Plaques and Autofluorescent Lipofuscin Aggregates in Alzheimer's Disease Brain: A Confocal Microscopy Approach” in Amyloid Proteins. </plain></SENT>
<SENT sid="50" pm="."><plain>Methods and Protocols, Volume 1179 in Methods Molecular Biology Series (ISBN: 978-1-4939-7815-1); Series Ed.: Walker, John M. Humana Press-Springer. </plain></SENT>
</text></p></caption><graphic xlink:href="fnins-12-00464-g0001"/></fig></SecTag></sec><sec id="s3"><title><text><SENT sid="52" pm="."><plain>Mechanisms of lipofuscin accumulation </plain></SENT>
</text></title><sec><title><text><SENT sid="53" pm="."><plain>Altered cellular proteostasis </plain></SENT>
</text></title><p><text><SENT sid="54" pm="."><plain>Three main mechanisms actively maintain cellular proteostasis: (i) degradation by the ubiquitin-proteasome system (UPS); (ii) re-folding and suppression of aggregates by heat shock proteins; and (iii) clearing of abnormal cell contents by lysosome-mediated autophagy (macroautophagy) (Mizushima et al., 2004; Mizushima, 2007). </plain></SENT>
<SENT sid="55" pm="."><plain>Both under normal and pathological conditions, the combination of these pathways are also possible (Fortun et al., 2003, 2005; Hara et al., 2006), including chaperone-mediated autophagy (Kaushik and Cuervo, 2012) and the ubiquitin-mediated autophagy required for the UPS system (Opalach et al., 2010). </plain></SENT>
</text></p><p><text><SENT sid="56" pm="."><plain>With aging, cellular proteostasis becomes less effective, hampering degradation of misfolded proteins, which in turn expose their hydrophobic domains and tend to form high-order complexes with other perinuclear/centrosomal-proximal proteins that are prone to aggregate into aggresomes (Kettern et al., 2011; Richter-Landsberg and Leyk, 2013; Seiberlich et al., 2013; Popovic et al., 2014; An and Statsyuk, 2015; Rodolfo et al., 2018). </plain></SENT>
<SENT sid="57" pm="."><plain>Then, upon lysosomal uptake of these aggregates via macroautophagy, highly cross-linked materials such as LF accumulate within the lysosomes (Höhn and Grune, 2013). </plain></SENT>
<SENT sid="58" pm="."><plain>Thus, although most of intracellular LF is located in the lysosomes, after inhibition of the macroautophagy pathway, LF can accumulate also in the cytosol (Höhn and Grune, 2013). </plain></SENT>
</text></p><p><text><SENT sid="59" pm="."><plain>These authors propose a mechanism by which the presence of high amounts of LF inhibit the proteasome, preventing the degradation of oxidized proteins and increasing the formation of free radicals, leading to cytotoxicity (Sitte et al., 2000; Ryhänen et al., 2009; Höhn et al., 2011). </plain></SENT>
<SENT sid="60" pm="."><plain>Then, oxidized proteins further accumulate and tend to aggregate (Höhn and Grune, 2013; Reeg and Grune, 2015). </plain></SENT>
<SENT sid="61" pm="."><plain>Hence, the 20S proteasome binds to the surface of LF aggregates at patches rich in unfolded oxidized proteins, but it remains attached, unable to degrade the LF due to its cross-linked nature (Reeg and Grune, 2015). </plain></SENT>
<SENT sid="62" pm="."><plain>In turn, lysosomal LF appears to impair autophagy and lysosomal degradation, resulting in increased reactive oxygen species (ROS) generation, protein oxidation, further aggregation, and further LF formation (Terman and Brunk, 2004). </plain></SENT>
<SENT sid="63" pm="."><plain>Moreover, cytosolic LF deposits produce ROS, decreasing cellular viability by defective cytosolic protein degradation (Grune et al., 2001; Höhn and Grune, 2013; Lei et al., 2017). </plain></SENT>
</text></p><p><text><SENT sid="64" pm="."><plain>In healthy conditions, the functional cost of proteostasis is high, but essential (Rangaraju et al., 2009; König et al., 2017). </plain></SENT>
<SENT sid="65" pm="."><plain>A consequence of the inhibition of the proteasome system is the decreased degradation of pro-apoptotic proteins (including c-jun, Bax, and p27), triggering the initiation of the apoptotic cascade (Powell et al., 2005), as well as the blockage of NFkB nuclear translocation and signal transduction (Powell et al., 2005; Reeg and Grune, 2015). </plain></SENT>
<SENT sid="66" pm="."><plain>Thus, cells overloaded with cytosolic and lysosomal LF may become dysfunctional and undergo apoptotic proteostasis-mediated cell death (Powell et al., 2005; Höhn et al., 2011). </plain></SENT>
</text></p><p><text><SENT sid="67" pm="."><plain>Additionally, LF ability to incorporate different metals contributes to reactive oxygen species (ROS) generation through the Fenton reaction and further protein oxidation and LF formation (Jolly et al., 1995; Tokutake et al., 1995; Reeg and Grune, 2015). </plain></SENT>
<SENT sid="68" pm="."><plain>For example, in Mn2+-exposed wild-type mice, it was observed an increased number of LF granules associated with neurodegenerating spiral ganglion neurons (Ohgami et al., 2016). </plain></SENT>
<SENT sid="69" pm="."><plain>Similarly, in ferritin light chain gene transgenic mice, it was shown the accumulation of LF granules within iron deposits, particularly at degenerating regions of the cerebellum and striatum (Maccarinelli et al., 2015). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="70" pm="."><plain>Mitochondrial involvement in lipofuscinogenesis </plain></SENT>
</text></title><p><text><SENT sid="71" pm="."><plain>The oxidative stress and the accumulated mitochondrial DNA mutations during lifetime lead to impairment metabolism of mitochondria, which in turn yields further oxidative stress by ROS production through oxidative phosphorylation. </plain></SENT>
<SENT sid="72" pm="."><plain>Cellular quality control mechanisms activate mitophagy to eliminate non-functional mitochondria by the lysosomal system (Atkins et al., 2016; Rodolfo et al., 2018), and then, the lysosomes accumulate non-degraded molecules, such as the mitochondrial small hydrophobic ATP-synthase subunit-c, which appears to be the main component of LF in neuronal ceroid lipofuscinosis diseases (Ezaki et al., 1995; Vidal-Donet et al., 2013). </plain></SENT>
<SENT sid="73" pm="."><plain>During aging, mitochondrial repair systems are further compromised by a general reduction of macroautophagy and downregulation of specific mitochondrial proteases, which are responsible for the degradation of oxidatively modified proteins (Ngo and Davies, 2007; Davies, 2014; König et al., 2017). </plain></SENT>
</text></p><p><text><SENT sid="74" pm="."><plain>These findings underscore an important crosstalk between mitochondria and lysosomes during aging that directly involves LF and other macromolecular aggregates (Terman et al., 2010). </plain></SENT>
<SENT sid="75" pm="."><plain>Accumulation of LF within the lysosomes leads to reduced autophagy and lower turnover of effective mitochondria. </plain></SENT>
<SENT sid="76" pm="."><plain>In turn, functionally deficient mitochondria generate increased ROS levels that further intensifies lipofuscinogenesis in a feedback loop of dysfunctional mitochondria and lysosomes, resulting in enhanced oxidative stress, lower energy production and dysfunction of the catabolic pathways (Brunk and Terman, 2002; Terman et al., 2010). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="77" pm="."><plain>Lipid metabolism </plain></SENT>
</text></title><p><text><SENT sid="78" pm="."><plain>As lipids are one of the main components of LF, a dysfunction of lipid metabolism has been suggested for the synthesis and accumulation of LF. </plain></SENT>
<SENT sid="79" pm="."><plain>Thus, Hebbar and collaborators have proposed that the buildup of LF deposits is a direct consequence of an imbalance in brain ceramides and sphingosines at early stages of neurodegeneration (Hebbar et al., 2017). </plain></SENT>
<SENT sid="80" pm="."><plain>Zhao and collaborators also demonstrated that defective ceramide biosynthesis causes neurodegeneration, suggesting a novel mechanism for LF formation (Zhao et al., 2011). </plain></SENT>
<SENT sid="81" pm="."><plain>Similarly, Pan and collaborators demonstrated in an in vivo knock-out mouse model that neuraminidases 3 and 4 play a key role in the central nervous system (CNS) function through the catabolism of gangliosides, and the prevention of their conversion into LF aggregates (Pan et al., 2017). </plain></SENT>
<SENT sid="82" pm="."><plain>Additionally, Horie and collaborators demonstrated that LF is also constituted by glycation products which interact through Schiff base reactions with protein-lipid complexes (Horie et al., 1997). </plain></SENT>
</text></p><p><text><SENT sid="83" pm="."><plain>The various mechanisms of production and accumulation of LF discussed within this section depict a complex panorama in which the lysosomes play a central role in lipofuscinogenesis. </plain></SENT>
<SENT sid="84" pm="."><plain>Thus, the increasing amount of LF deposits during aging in certain post-mitotic tissues, and the massive buildup of LF in disorders associated with lysosomal dysfunction, such as Neuronal Ceroid Lipofuscinosis (see next sections), are arguably some of the best established findings about the pathophysiological accumulation of LF. </plain></SENT>
<SENT sid="85" pm="."><plain>However, due to its diverse origin, amalgamated composition, cross-linked nature, autofluorescent properties, and its age-related ubiquitous distribution within the CNS, the role of LF in neurodegeneration is still yet to be elucidated. </plain></SENT>
<SENT sid="86" pm="."><plain>Moreover, the analysis of a potential pathophysiological role of LF has been hampered by the absence of adequate animal models and their corresponding controls; thus, underscoring the need for simpler system study models. </plain></SENT>
</text></p></sec></sec><sec id="s4"><title><text><SENT sid="87" pm="."><plain>In vitro lipofuscin synthesis for neurodegenerative studies </plain></SENT>
</text></title><p><text><SENT sid="88" pm="."><plain>In order to explore the physicochemical properties, interactions, and functions of LF, it is essential to have a reliable system to produce it, either in vitro or in in vivo models. </plain></SENT>
<SENT sid="89" pm="."><plain>Numerous authors have described different approaches to obtain LF from diverse biological sources. </plain></SENT>
<SENT sid="90" pm="."><plain>For example, several methods have been established to produce N-retinylidene-N-retinylethanolamine (A2E), which is one of the principal fluorescent components of LF from retinal pigmented epithelial cells (Parish et al., 1998). </plain></SENT>
</text></p><p><text><SENT sid="91" pm="."><plain>Other authors, considering that LF is the final product of a peroxidation reaction between lipids and proteinaceous components within the cell, have used the process of photo-oxidation of subcellular fractions to obtain high quantities of “synthetic” LF through UV irradiation (Nilsson and Yin, 1997; Höhn et al., 2010; Frolova et al., 2015). </plain></SENT>
<SENT sid="92" pm="."><plain>Interestingly, these studies demonstrate that mitochondria can produce LF granules without oxidative factors (oxygen saturation or pro-oxidants) and that the presence of lipids is not an absolute requirement for LF formation (Frolova et al., 2015). </plain></SENT>
<SENT sid="93" pm="."><plain>These methods allow the synthesis of LF similar to that found in post-mitotic cells with analogous composition and properties. </plain></SENT>
<SENT sid="94" pm="."><plain>However, for some experimental setups, naturally produced LF may be more suitable and relevant. </plain></SENT>
<SENT sid="95" pm="."><plain>Arguably, LF fractions purified from the retinal pigment epithelium (RPE) or derived from cell culture models through organic solvent extractions are the most widely used procedures (Folch et al., 1957; Lamb and Simon, 2004; Boulton, 2014; Feldman et al., 2015). </plain></SENT>
</text></p></sec><sec id="s5"><title><text><SENT sid="96" pm="."><plain>Lipofuscin in neurodegeneration </plain></SENT>
</text></title><p><text><SENT sid="97" pm="."><plain>As mentioned above, LF is considered a hallmark of cellular aging. </plain></SENT>
<SENT sid="98" pm="."><plain>In fact, the accumulation with time of LF pigments within post-mitotic cells is so constant that it is used to calculate the age of crustacean (Pearse, 1985; Maxwell et al., 2007). </plain></SENT>
<SENT sid="99" pm="."><plain>In normal aged mammal brains, LF distributes delineating a specific senescence pattern that correlates with altered neuronal cytoskeleton and cellular trafficking. </plain></SENT>
<SENT sid="100" pm="."><plain>Thus, as we age, the brain of the human adult becomes heavily laden with intraneuronal deposits of LF and neuromelanin pigment (Braak et al., 1999). </plain></SENT>
<SENT sid="101" pm="."><plain>However, in neurodegenerative disorders, LF aggregates appear to increase not only with age but also with pathological processes such as neuronal loss, proliferation, and activation of glial cells, and a repertoire of cellular alterations, including oxidative stress, proteasome, lysosomal, and mitochondrial dysfunction (González-Scarano and Baltuch, 1999; Grune et al., 2004; Keller et al., 2004; Riga et al., 2006a; Hebbar et al., 2017; Wellings et al., 2017). </plain></SENT>
</text></p><sec><title><text><SENT sid="102" pm="."><plain>Neuronal ceroid lipofuscinosis </plain></SENT>
</text></title><p><text><SENT sid="103" pm="."><plain>Arguably, the most relevant group of disorders clearly related with LF deposits are the neuronal ceroid lipofuscinoses (NCLs). </plain></SENT>
<SENT sid="104" pm="."><plain>NCLs are a group of rare neurodegenerative disorders characterized by intracellular (and at a minor extent extracellular) accumulation of a fluorescent lipopigment called “ceroid lipofuscin” (Kohan et al., 2011). </plain></SENT>
<SENT sid="105" pm="."><plain>Clinically, NCLs are associated with variable, progressive symptoms, including dementia, visual loss, seizures, and cerebral atrophy (Grubman et al., 2014). </plain></SENT>
<SENT sid="106" pm="."><plain>Genetically, NCLs are a homogeneous group associated with mutations in at least 14 affected genes termed as from CLN1 to CLN14 generally with autosomal recessive inheritance (for an updated list of mutation check <ext-link ext-link-type="uri" xlink:href="http://www.ucl.ac.uk/ncl/mutation.shtml">http://www.ucl.ac.uk/ncl/mutation.shtml</ext-link>). </plain></SENT>
<SENT sid="107" pm="."><plain>Mutations in these genes are associated with several distinct NCL disorders, which share several common features, including inflammation, lysosomal LF deposits, and lipid abnormalities, but have different age at onset, clinical phenotypes, and progression rates (Grubman et al., 2014). </plain></SENT>
<SENT sid="108" pm="."><plain>In general, NCLs are considered lysosomal storage diseases; although, they also exhibit characteristics that set them apart from typical lysosomal storage diseases (Mink et al., 2013; Nita et al., 2016). </plain></SENT>
<SENT sid="109" pm="."><plain>One prototypical example of these disorders is NCL2. </plain></SENT>
<SENT sid="110" pm="."><plain>The NCL2 disease is one type of inherited infantile neuronal ceroid lipofuscinoses caused by the deficiency of the lysosomal enzyme tripeptidyl peptidase 1, which affects the brain and the retina and is characterized by the lysosomal accumulation of ceroid LF (Williams et al., 2017). </plain></SENT>
<SENT sid="111" pm="."><plain>Interestingly, related to the presence of “normal” LF aggregates in tissue, the diagnosis of adult forms of NCL is challenging due to the misinterpretation of age-related LF deposits as abnormal storage material, with more than one-third of cases misdiagnosed; therefore, stressing the need of analysis of known causative genes and the identification of newly associated genes (Berkovic et al., 2016). </plain></SENT>
</text></p><p><text><SENT sid="112" pm="."><plain>Outside this group, several other disorders show resemblance with the NCLs as they progress with ceroid LF deposition. </plain></SENT>
<SENT sid="113" pm="."><plain>Among them, we highlight disorders that are associated with mutations in the CLC-3 (a member of the CLC chloride channel family) gene (Yoshikawa et al., 2002), the ClC-7 (chloride channel of late endosomes and lysosomes) gene (Kasper et al., 2005; Weinert et al., 2010), the cathepsin D (a major lysosomal protease) gene (Koike et al., 2000), as well as neuronopathic osteopetrosis associated to defects in the genes TCIRG1 or ClC-7 (Steward, 2003). </plain></SENT>
<SENT sid="114" pm="."><plain>In these disorders, far from being a consequence of the neurodegenerative process, LF appears to have an important role in the etiology of clinical symptoms. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="115" pm="."><plain>Age-related macular degeneration </plain></SENT>
</text></title><p><text><SENT sid="116" pm="."><plain>Age-related macular degeneration (AMD) is a degenerative disorder of the RPE of the central retina, which represents the most important cause of vision loss in the elderly. </plain></SENT>
<SENT sid="117" pm="."><plain>It has a multifactorial etiopathology and is characterized by the presence of deposits of lysosomal origin, such as LF, melanolipofuscin, and melanosomes (Rodríguez-Muela et al., 2013; Pollreisz et al., 2018). </plain></SENT>
<SENT sid="118" pm="."><plain>It is generally accepted that LF can contribute to the pathogenesis of AMD. </plain></SENT>
<SENT sid="119" pm="."><plain>Due to its nature as a fluorochrome, exposure of the spherical microparticles of LF at the RPE to blue light produces a phototoxic and proinflammatory effect, mediated by reactive oxygen intermediates (ROI), which contributes to atrophy in AMD patients (Brunk and Terman, 2002; Pollreisz et al., 2018). </plain></SENT>
<SENT sid="120" pm="."><plain>Interestingly, A2E, a major LF fluorophore that accumulates during AMD progression, appears to be directly involved in the photo-induced oxidative stress, and the disruption of membrane integrity at the RPE (Lamb and Simon, 2004). </plain></SENT>
<SENT sid="121" pm="."><plain>Similarly, the levels of A2E in the retina of an AMD mouse model [Ccl2(-/-)/Cx3cr1(-/-) mice] were significantly higher when compared to wild-type retina (Tuo et al., 2007). </plain></SENT>
</text></p><p><text><SENT sid="122" pm="."><plain>In addition, Stargardt disease, the most common form of inherited juvenile macular degeneration which is associated with progressive vision loss caused by the death of photoreceptor cells in the macula of the retina, presents significant LF accumulation in the lysosomal compartment of the retinal pigment epithelium of the eye (Adler et al., 2015). </plain></SENT>
</text></p><p><text><SENT sid="123" pm="."><plain>Furthermore, LF particles have been recently detected in the aged human optic nerve from controls, and glaucoma or AMD donors (de Castro et al., 2013). </plain></SENT>
<SENT sid="124" pm="."><plain>Although similar amounts of LF were observed among the different groups, the authors found that optic nerves derived from donors with glaucoma contain larger LF particles compared to those observed in the age-matched control and AMD groups. </plain></SENT>
<SENT sid="125" pm="."><plain>Moreover, they observed that optic nerves from glaucoma donors display a smaller diameter and higher concentration of LF relative to age-matched controls, suggesting that the increased LF levels may have an active role in inducing pro-inflammatory phenotypes in microglia and astrocytes, thus exacerbating optic nerve damage (de Castro et al., 2013). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="126" pm="."><plain>Frontotemporal degeneration </plain></SENT>
</text></title><p><text><SENT sid="127" pm="."><plain>Heterozygous loss-of-function mutations in the progranulin gene (GRN) are associated with frontotemporal degeneration with TDP-43-positive inclusions (FTD-TDP). </plain></SENT>
<SENT sid="128" pm="."><plain>FTD is highly heterogeneous in its clinical presentation, age at onset and duration of the disease even within the same families, suggesting the mediation of additional modifying genes. </plain></SENT>
<SENT sid="129" pm="."><plain>Strikingly, while the deletion c.813_816del (rs63749877) in the GRN gene in heterozygosis is also associated with FTD, the same mutation when presented in homozygosis causes adult-onset NCL, revealing a remarkable link between neurodegeneration and lipofuscinogenesis (Smith et al., 2012). </plain></SENT>
<SENT sid="130" pm="."><plain>More recently, Ward and collaborators have demonstrated that heterozygous GRN mutation carriers also present preclinical retinal lipofuscinosis, as well as increased lipofuscinosis and intracellular NCL-like deposits in the cerebral cortex (Ward et al., 2017). </plain></SENT>
</text></p><p><text><SENT sid="131" pm="."><plain>In animal models, progranulin deficiency partially recapitulates FTD behavioral abnormalities and neuropathological changes, including altered dendritic morphology and synaptic deficits in the hippocampus (Petkau et al., 2016). </plain></SENT>
<SENT sid="132" pm="."><plain>Aged progranulin-deficiency mice also show increased lipofuscinosis, microgliosis, and astrogliosis, as well as mild regional specific cell loss. </plain></SENT>
<SENT sid="133" pm="."><plain>However, conditional loss of progranulin in neurons is not sufficient to cause neuronal ceroid lipofuscinosis-like neuropathology in mice, as progranulin expressed by the microglia appears to compensate the neuronal deficit of progranulin (Petkau et al., 2017). </plain></SENT>
<SENT sid="134" pm="."><plain>Interestingly, although neurodegeneration and LF accumulation clearly correlate in most animal models, in this progranulin deficiency mouse model, it has been shown that deletion of the TMEM106B (Transmembrane protein 106B) gene normalizes lysosomal activity and rescues FTD-related behavioral abnormalities and retinal degeneration, without showing a decrease in LF accumulation (Klein et al., 2017); therefore, suggesting that neurodegeneration and lipofuscinogenesis are independent processes. </plain></SENT>
<SENT sid="135" pm="."><plain>As recent evidence suggests that progranulin is a key player for the appropriate maintenance of lysosomal function during aging (Zhou et al., 2017), these data point out to a common role of endolysosomal dysfunction for FTD neurodegeneration and NCL pathology. </plain></SENT>
<SENT sid="136" pm="."><plain>Further studies should be aimed at elucidating the specific pathological role LF in FTD neurodegeneration. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="137" pm="."><plain>Parkinson's disease </plain></SENT>
</text></title><p><text><SENT sid="138" pm="."><plain>In PD, LF granular aggregates and upregulation of α-synuclein (α-syn) appear to be directly involved in the selective degeneration of dopaminergic neurons in the SNC (Lv et al., 2011). </plain></SENT>
<SENT sid="139" pm="."><plain>Additionally, increased expression of divalent metal transporter 1 and decreased expression of ferroportin 1 seem to associate with elevated levels of iron at the SNC; therefore, suggesting that increased iron levels are involved in the selective degeneration of dopaminergic neurons (Lv et al., 2011). </plain></SENT>
<SENT sid="140" pm="."><plain>Interestingly, Braak and collaborators found that only those neuronal types containing LF or neuromelanin show an increased susceptibility to develop pathological changes including cytoskeletal changes and α-syn Lewy body deposits (Braak et al., 2001). </plain></SENT>
<SENT sid="141" pm="."><plain>Moreover, α-syn appears to be a constituent of the lipofuscin deposits present in the neurons of the substantia nigra of PD patients and in nigral neurons of MPTP-treated mice, suggesting that LF deposits may have a role in the selective nigral degeneration (Braak et al., 2001; Meredith et al., 2002). </plain></SENT>
</text></p><p><text><SENT sid="142" pm="."><plain>Similarly, in Deiters' neurons, which express the cytostructural non-phosphorylated neurofilament protein (NPNFP), Wellings and collaborators found a strong inverse correlation between NPNFP intensity and LF autofluorescence, suggesting that these changes contribute to degeneration of postural reflexes observed in PD (Wellings et al., 2017). </plain></SENT>
<SENT sid="143" pm="."><plain>According to the authors, LF accumulation may lead to cytoskeletal abnormalities, including decreased NPNFP levels and disrupting Deiters' neurons functions, even in neuropathological normal controls (Wellings et al., 2017). </plain></SENT>
<SENT sid="144" pm="."><plain>Interestingly, non-dopaminergic areas as the medullary nuclei that are early affected during PD progression (Braak et al., 2001) present concomitant accumulation of Lewy bodies and LF granules (Wellings et al., 2017). </plain></SENT>
<SENT sid="145" pm="."><plain>Similarly, Braak and collaborators described that Lewy bodies are normally found within the LF deposits of medullary neurons (Braak et al., 2003). </plain></SENT>
<SENT sid="146" pm="."><plain>Opposite, Drach and collaborators found reduced intraneuronal LF content in patients with Lewy body dementia (LBD) compared to AD and controls, arguing that these findings are related to either a reduced metabolic rate in LBD or to an uneven use of neuroleptics among groups (Drach et al., 1998). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="147" pm="."><plain>Alzheimer's disease </plain></SENT>
</text></title><p><text><SENT sid="148" pm="."><plain>In AD, at initial stages of neurodegeneration, affected pyramidal neurons in prefrontal cortex and hippocampus increasingly accumulate lysosomes at the basal pole and then extensively in the perikarya and proximal dendrites (Cataldo et al., 1994). </plain></SENT>
<SENT sid="149" pm="."><plain>Lysosomes become filled with LF aggregates as a result of initial autophagocytosis and lysosomal system activation. </plain></SENT>
<SENT sid="150" pm="."><plain>At more advanced stages of neurodegeneration, surviving neurons show a great cytoplasmic accumulation of large LF deposits. </plain></SENT>
<SENT sid="151" pm="."><plain>Interestingly, following neuronal death, LF aggregates are found in the extracellular space, usually associated with senile β-amyloid plaques (Cataldo et al., 1994). </plain></SENT>
<SENT sid="152" pm="."><plain>Tokutake and collaborators suggested that LF granules associated to the senile plaques are the responsible for binding aluminum, providing an argument to explain the divergent reports on the presence of this metal in AD plaques (Tokutake et al., 1995). </plain></SENT>
</text></p><p><text><SENT sid="153" pm="."><plain>LF is formed when products of lipid peroxidation (reactive aldehydes and lipid radicals) attack lipids, proteins and other susceptible groups, either locally or far from their origin, because they are diffusible and can migrate and act at a distance. </plain></SENT>
<SENT sid="154" pm="."><plain>Consequently, lipid peroxidation end-products (also called LF-like pigments), are produced and their distribution could be either restricted to a specific tissue or tissue domains or be systemically distributed. </plain></SENT>
<SENT sid="155" pm="."><plain>For instance, in brains from AD patients, the lipid peroxidation product malondialdehyde, an important component of the phospholipid bilayer membranes of neurons, is significantly increased (Dalle-Donne et al., 2006); thus, promoting free radical damage, protein cross-linking and decreased membrane fluidity (Goldstein and McDonagh, 1976; Chmátalová et al., 2016). </plain></SENT>
<SENT sid="156" pm="."><plain>Thus, the reactive compounds from brain tissue can act like a messenger, diffusing through the bloodstream and attacking polyunsaturated fatty acids in membranes of erythrocytes or soluble plasma proteins leading to the formation of LF. </plain></SENT>
<SENT sid="157" pm="."><plain>In AD patients, it was found that erythrocyte-bound LF levels were significantly higher than those observed in controls (Goldstein and McDonagh, 1976; Skoumalová and Hort, 2012). </plain></SENT>
</text></p><p><text><SENT sid="158" pm="."><plain>In the same line, in the cerebral cortex of aged control and AD brains, a subset of neurons covered by perineuronal nets (PNs) are less frequently affected by LF accumulation. </plain></SENT>
<SENT sid="159" pm="."><plain>The polyanionic character of PNs appears to contribute to reducing local oxidative potential in the neuronal microenvironment by scavenging and binding redox-active iron (Morawski et al., 2004). </plain></SENT>
<SENT sid="160" pm="."><plain>Braak and Braak previously observed a similar effect related to cortical myelination. </plain></SENT>
<SENT sid="161" pm="."><plain>They found a clear inverse correlation between the average myelin content and the density of intraneuronal LF deposits, as well as with the appearance of the neurofibrillary changes associated with neurodegeneration, suggesting that the LF-laden neurons with a long, thin, and sparsely myelinated axon are prone to develop AD-related changes (Braak and Braak, 1998). </plain></SENT>
<SENT sid="162" pm="."><plain>Interestingly, LF deposits are also found to colocalize with β-amyloid plaques (Riga et al., 2006a; Moreira et al., 2010; Firlag et al., 2013). </plain></SENT>
<SENT sid="163" pm="."><plain>Altogether, these facts have set the basis for the hypothesis that the release of LF into the extracellular space following the death of neurons may substantially contribute to the formation of AD senile plaques and neurodegeneration (Giaccone et al., 2011). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="164" pm="."><plain>Huntington disease </plain></SENT>
</text></title><p><text><SENT sid="165" pm="."><plain>Huntington's disease (HD) is an inherited disorder caused by an autosomal dominant mutation in the Huntingtin gene (htt), related to the expansion of CAG triplet repeats, resulting in an extended polyglutamine stretch (polyQ) within the huntingtin protein, which becomes unstable, gradually damaging neuronal cells (Ross et al., 2014). </plain></SENT>
</text></p><p><text><SENT sid="166" pm="."><plain>Increased LF has been observed in the brain of people suffering from HD (Tellez-Nagel et al., 1974; Goebel et al., 1978; Braak and Braak, 1992; Vonsattel and Difiglia, 1998). </plain></SENT>
<SENT sid="167" pm="."><plain>Thus, in HD brains, Braak and Braak found that the loss of neurons at the subiculum was marked by the presence of extraneuronal deposits of LF within layers of pyramidal neurons (Braak and Braak, 1992). </plain></SENT>
<SENT sid="168" pm="."><plain>Later, Vonsattel and Difiglia described that neurons from HD cases “contain more lipofuscin and may be smaller than usually expected” (Vonsattel and Difiglia, 1998). </plain></SENT>
</text></p><p><text><SENT sid="169" pm="."><plain>Similarly, a transgenic mouse model for HD has shown that the formation of huntingtin neuronal intranuclear inclusions is accompanied by the appearance of accumulations of LF within the cytoplasm of neurons even in juvenile mice from 12 weeks old (Davies et al., 1997, 1999). </plain></SENT>
<SENT sid="170" pm="."><plain>Interestingly, Zheng and collaborators have demonstrated that the expression of full-length htt lacking its polyglutamine stretch (ΔQ-htt) in a mouse model of HD was able to rescue the HD phenotype, reducing huntingtin aggregates and LF levels, motor and behavioral deficits and extending life span (Zheng et al., 2010). </plain></SENT>
<SENT sid="171" pm="."><plain>The authors also found that ΔQ-htt expression increases autophagosome synthesis, arguing that this autophagy upregulation may be beneficial in diseases caused by toxic intracellular aggregate-prone proteins (Zheng et al., 2010), as it is the case of most neurodegenerative disorders. </plain></SENT>
<SENT sid="172" pm="."><plain>As we discussed previously, the observed normalization of LF levels may be directly correlated with autophagosome function restoration. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="173" pm="."><plain>Diabetic encephalopathy </plain></SENT>
</text></title><p><text><SENT sid="174" pm="."><plain>Diabetic encephalopathy refers to a pathology that courses with brain damage associated with diabetes type 1 or type 2, caused by either acute hypoglycemia or severe hyperglycemia. </plain></SENT>
<SENT sid="175" pm="."><plain>In type 2 diabetes, diabetic encephalopathy increases the risk of developing AD and other forms of dementia, while in type 1 diabetic encephalopathy is less likely to develop into dementia as the patients are younger, but type 1 diabetics with encephalopathy are more likely to develop learning disabilities and deficits in memory retrieval. </plain></SENT>
<SENT sid="176" pm="."><plain>In a mouse model of type 1 diabetes induced by treatment with streptozotocin, Sugaya and collaborators found that diabetes onset caused accelerated accumulation of LF granules in trigeminal neurons (Sugaya et al., 2004). </plain></SENT>
<SENT sid="177" pm="."><plain>Later, Alvarez and collaborators demonstrated that in the same streptozotocin model, the animals showed a phenotype similar to diabetic encephalopathy with mild neurodegeneration in the dentate gyrus and a strong decrease in hippocampal proliferation. </plain></SENT>
<SENT sid="178" pm="."><plain>Interestingly, the authors found a marked enhancement of intracellular LF deposits, characteristic of increased oxidative stress and aging in both, the hilus and the subgranular zone and granular cell layer (Alvarez et al., 2009). </plain></SENT>
<SENT sid="179" pm="."><plain>In a different model of diabetes, induced by administration of alloxan, the animals also showed signs of diabetic encephalopathy with rapidly progressing neuronal and glial losses in the primary somatosensory cortex and hippocampus, accompanied by accumulation of LF in neocortical neurons (Volchegorskii et al., 2013). </plain></SENT>
<SENT sid="180" pm="."><plain>These findings with different mouse models of diabetes underscore the exquisite sensitivity of neuronal tissues to LF buildup, suggesting an active neurotoxic role of these aggregates. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="181" pm="."><plain>Other conditions </plain></SENT>
</text></title><p><text><SENT sid="182" pm="."><plain>Aggregates of lipofuscin or ceroid LF are found in various metabolic disorders associated with mutations in several genes. </plain></SENT>
<SENT sid="183" pm="."><plain>Thus, in familial spastic paraplegia cases associated with neurodegeneration and gliosis, a marked presence of LF deposits in surviving neurons has been observed (Wakabayashi et al., 2001). </plain></SENT>
</text></p><p><text><SENT sid="184" pm="."><plain>In rat cerebral cortex, cathepsin D (but no cathepsin B) has been found to colocalize with LF aggregates in the extracellular space (Jung et al., 1999) that in turn activates the p38 MAP kinase cascade through the increased intracellular generation of ROS, and promote the expression of iNOS and CAT-2, thereby inducing NO overproduction (Yamasaki et al., 2007). </plain></SENT>
<SENT sid="185" pm="."><plain>Cathepsin F-deficient mice (cat F-/-) display CNS neurons with large accumulations of lysosomal LF (Tang et al., 2006). </plain></SENT>
<SENT sid="186" pm="."><plain>Also in a murine model, it was observed that chronic sleep disruption resulted in frequent activation of wake-activated neurons (WAN), which promotes mitochondrial metabolic stress and increased LF accumulation in a subgroup of WAN (Zhu et al., 2015). </plain></SENT>
<SENT sid="187" pm="."><plain>On the other hand, chronic alcohol consumption induces increasing LF deposition in rat hippocampal neurons (Borges et al., 1986) and Purkinje (Lewandowska et al., 1994; Wenisch et al., 1997; Dlugos, 2015). </plain></SENT>
<SENT sid="188" pm="."><plain>Mice lacking the expression of glycerophosphodiester phosphodiesterase 2 (a six-transmembrane protein that cleaves glycosylphosphatidylinositol anchors) show early neurodegeneration with vacuolization, microgliosis, cytoskeletal accumulation, and LF deposition followed by astrogliosis and cell death (Cave et al., 2017). </plain></SENT>
</text></p><p><text><SENT sid="189" pm="."><plain>As a whole, these data from human disorders and mouse models point to a common dyshomeostasis of the endolysosomal pathway not necessarily associated with oxidative stress and mitochondrial dysfunction, but in which LF is always present, likely acting as a pathology booster. </plain></SENT>
</text></p></sec></sec><sec id="s6"><title><text><SENT sid="190" pm="."><plain>Therapeutic approaches </plain></SENT>
</text></title><p><text><SENT sid="191" pm="."><plain>As LF and other lipopigments, such as ceroids, represent a marker of post-mitotic normal and pathologic aging, and they have been causally associated with neuropathological changes, LF elimination has been suggested as a suitable target in anti-aging therapies (Riga et al., 2006b). </plain></SENT>
<SENT sid="192" pm="."><plain>Recently, a clinical trial (ClinicalTrials.gov identifier NCT00028262) for the treatment of patients with infantile NCL associated with mutations in the CLN1 gene encoding for palmitoyl-protein thioesterase-1 has been carried out by orally administering the nucleophilic small molecules cysteamine bitartrate and N-acetylcysteine, aiming at the reduction of ceroid lipofuscin and granular osmiophilic deposits (GROD) (Levin et al., 2014). </plain></SENT>
<SENT sid="193" pm="."><plain>The results of the trial indicated that the patients presented a significant decrease of GROD in peripheral leukocytes, together with improved functional and behavioral parameters and fewer seizures. </plain></SENT>
<SENT sid="194" pm="."><plain>However, the results of these trials did not support the idea that the removal of the storage deposits correlates with a clinical benefit or halt neurodegeneration (Levin et al., 2014; Neverman et al., 2015). </plain></SENT>
</text></p><p><text><SENT sid="195" pm="."><plain>There are also several approaches in the field of AMD targeting LF or its precursors. </plain></SENT>
<SENT sid="196" pm="."><plain>Thus, two visual cycle inhibitors, namely Fenretinide and Emixustat, have been used trying to prevent the phototoxicity and proinflammatory effects of LF. </plain></SENT>
<SENT sid="197" pm="."><plain>A phase II clinical trial with Fenretinide (NCT00429936) did not show efficacy to halt the growth rate of geographic atrophy (GA) in AMD, but patients seemed to tolerate it well. </plain></SENT>
<SENT sid="198" pm="."><plain>A phase IIa clinical trial with Emixustat (NCT01002950) showed a biological effect in GA in AMD patients. </plain></SENT>
<SENT sid="199" pm="."><plain>A Phase II/III study (NCT01802866) has been completed, but no results are yet available (Bandello et al., 2017) (information checked in May 2018). </plain></SENT>
</text></p><p><text><SENT sid="200" pm="."><plain>A study with rats showed that treatment with melatonin or coenzyme Q10 for 4 weeks reduced the LF content of the hippocampus and carbonyl level (Abd El Mohsen et al., 2005). </plain></SENT>
<SENT sid="201" pm="."><plain>In fish, analysis of age-dependent mortality revealed that dietary restriction prevented the accumulation of LF in the liver and the neurodegeneration marker FluoroJade B in the brain (Terzibasi et al., 2009). </plain></SENT>
</text></p><p><text><SENT sid="202" pm="."><plain>Regenerative neuroactive factors have been also suggested to enhance antioxidative defense, stimulate brain anabolism and potentiate lysosomal system, while decreasing LF levels. </plain></SENT>
<SENT sid="203" pm="."><plain>By acting also on glial cells, the mechanism of clearance of LF deposits and other residues appear to be also improved (Riga et al., 2006b). </plain></SENT>
</text></p><p><text><SENT sid="204" pm="."><plain>Interestingly, the presence of LF appears to have a positive effect for certain therapies with antitumor drugs that produce free radicals, whose action is inhibitory or deadly for tumor cells (Schwarzburd and Aslanidi, 1991). </plain></SENT>
<SENT sid="205" pm="."><plain>Under the oxidative stress provoked by the drugs, it appears that normal cells respond with an increase in the amount of LF in their lysosomes and cytoplasm hampering further damage. </plain></SENT>
<SENT sid="206" pm="."><plain>Opposite, cancer cells, unable to accumulate LF particles are more susceptible to the action of the drug. </plain></SENT>
<SENT sid="207" pm="."><plain>In this sense, Schwartsburd in 1995 put forward the idea that lipofuscinogenesis is an adaptative cell response to oxidative stress that improves cell survival under harsh conditions (Schwartsburd, 1995). </plain></SENT>
<SENT sid="208" pm="."><plain>In Drosophila melanogaster, a similar protective effect of LF is suggested by spin gene mutants that presented degeneration of adult neural cells, while surviving neurons were atrophied with heavy LF deposition (Nakano et al., 2001). </plain></SENT>
<SENT sid="209" pm="."><plain>However, once a certain threshold of LF level is trespassed, and the system is overload, this mechanism appears to produce the opposite effect, by multiplying the effects of oxidative stress. </plain></SENT>
</text></p></sec><SecTag type="CONCL"><sec id="s7"><title><text><SENT sid="210" pm="."><plain>Concluding remarks </plain></SENT>
</text></title><p><text><SENT sid="211" pm="."><plain>As we grow older, LF gets accumulated in post-mitotic cells due to its highly complex cross-linked structure that is not amenable to degradation, as a marker of partially dysfunctional metabolism. </plain></SENT>
<SENT sid="212" pm="."><plain>Thus, LF has been traditionally considered a consequence of “normal” aging that gets increasingly deposited as cellular garbage, starting early in life. </plain></SENT>
</text></p><p><text><SENT sid="213" pm="."><plain>Similarly, pathognomonic protein deposits such as amyloid beta plaques, tau neurofibrillary tangles or alpha-synuclein Lewy bodies are present even in normal individuals, and their accumulation appears to be the result of a protective cellular response to handle an excess of misfolded proteins (Ross and Poirier, 2005). </plain></SENT>
<SENT sid="214" pm="."><plain>Thus, the process of LF formation may represent a protective neuronal mechanism by which molecules that are highly toxic in soluble form are sequestered in a more stable, less-toxic state as aggregates (Zhao et al., 2011). </plain></SENT>
<SENT sid="215" pm="."><plain>However, recent findings indicate that LF is not an inert byproduct of cells, but it rather actively alters cellular metabolism at different levels by inhibiting the proteasome, impairing autophagy and lysosomal degradation, and serving as a reservoir of metal ions leading to ROS generation and apoptotic cell death (reviewed in Reeg and Grune, 2015) (see also Figure 2). </plain></SENT>
<SENT sid="216" pm="."><plain>Additionally, the dispersed nature of the deposits, which are distributed throughout the tissue, may argue for a mechanism of LF diffusion and seeding for new LF aggregates. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="F2" position="float"><label>Figure 2</label><caption><p><text><SENT sid="217" pm="."><plain>Schematic representation of the role of LF at different points of cellular physiology. </plain></SENT>
<SENT sid="218" pm="."><plain>With aging, the levels of oxidative stress increase, causing the impairment of several interconnected cellular homeostatic pathways such as the endolysosomal and mitochondrial systems and leading to defective proteostasis, incomplete mitophagy and the activation of lipofuscinogenesis. </plain></SENT>
<SENT sid="219" pm="."><plain>On the one hand, lipofuscin accumulation harms the proteostasis pathway, further promoting oxidative stress, energetic imbalance, and increased lipofuscinogenesis. </plain></SENT>
<SENT sid="220" pm="."><plain>On the other hand, altered proteostasis together with endolysosomal dysfunction also obstruct the clearance of misfolded proteins, which may accumulate as seeds for protein aggregation contributing to neurodegeneration. </plain></SENT>
<SENT sid="221" pm="."><plain>As protein aggregates deposits within the brain tissue, LF formation also increases, hindering both vesicle trafficking and cellular physiology. </plain></SENT>
<SENT sid="222" pm="."><plain>Finally, as the cell is unable to deal with the cascade of damaging events it degenerates. </plain></SENT>
<SENT sid="223" pm="."><plain>Upon cell death, LF content is released to the parenchyma, where it can be found associated with pathognomonic protein deposits, such as amyloid beta plaques. </plain></SENT>
<SENT sid="224" pm="."><plain>These LF deposits recruit cellular debris and metals ions, provoking more oxidative stress, and microglial activation, which triggers neuroinflammation and proinflammatory interleukin production, thus contributing to expanding the neurodegeneration. </plain></SENT>
</text></p></caption><graphic xlink:href="fnins-12-00464-g0002"/></fig></SecTag><p><text><SENT sid="225" pm="."><plain>The presence of LF as a pathognomonic marker in both infantile-juvenile and adult neuronal ceroid lipofuscinoses, as well as its role as ROS amplifier mediated by UV-exposure in age-related macular degeneration, underscore the pathological role of LF in these groups of neurodegenerative disorders. </plain></SENT>
<SENT sid="226" pm="."><plain>However, the direct involvement of LF in other neurodegenerative disorders such as AD or PD is still a matter of debate. </plain></SENT>
</text></p><p><text><SENT sid="227" pm="."><plain>In order to discuss whether LF is a subproduct of defective cellular homeostasis associated with aging or it has a pathological role of its own in neurodegeneration, it is relevant to compare the temporal profile of accumulation of LF aggregates with pathognomonic protein deposits associated with diverse neurodegenerative disorders. </plain></SENT>
<SENT sid="228" pm="."><plain>Interestingly, the temporal pattern of accumulation is similar to the one observed for protein deposits in different neurodegenerative disorders (Braak et al., 2011; Ferrer et al., 2011; Del Tredici and Braak, 2016). </plain></SENT>
<SENT sid="229" pm="."><plain>According to the study by Braak and coworkers, in the case of AD, both β-amyloid and neurofibrillar pathological features are present very early in life (even in the first decade), and also as in the case of LF, their presence increases with age (Braak et al., 2011). </plain></SENT>
<SENT sid="230" pm="."><plain>However, these pathology markers are not associated with overt disease until they reach a certain threshold that varies with age. </plain></SENT>
<SENT sid="231" pm="."><plain>Thus, lipofuscinogenesis and neuropathogenesis of the main CNS degenerative conditions seem to share an equivalent temporal kinetics: early pathological changes and slow relentless development with late sensorial, motor and cognitive deterioration. </plain></SENT>
</text></p><p><text><SENT sid="232" pm="."><plain>Moreover, LF may also exert a neuropathological role by the dysregulation of protein homeostasis through its ability to sequester functional molecules and proteins (Hashemzadeh-Bonehi et al., 2006). </plain></SENT>
<SENT sid="233" pm="."><plain>Provided the hydrophobic nature of LF aggregates, a similar role sequestering other functional molecules and later release of diffusible molecules that are more neurotoxic cannot be ruled out. </plain></SENT>
<SENT sid="234" pm="."><plain>Additionally, the interaction with pathognomonic aggregation-prone proteins, such as Aβ, α-syn, or tau needs further research, but the presence of LF aggregates within neurodegeneration-specific protein deposits such as the AD senile plaques suggests an involvement of LF in pathogenesis (Cataldo et al., 1994; Giaccone et al., 2011) (see also Figure 1). </plain></SENT>
</text></p><p><text><SENT sid="235" pm="."><plain>Taken together, all these data suggest a neuropathological role of LF by impairing the same mechanisms and acting like other protein aggregates (e.g., amyloid beta, tau, alpha-synuclein) of different neurodegenerative diseases. </plain></SENT>
<SENT sid="236" pm="."><plain>Thus, we argue that LF plays a transversal function on both cellular senescence and across neurodegeneration. </plain></SENT>
<SENT sid="237" pm="."><plain>Provided that LF increasingly accumulates with age, and assuming the hypothesis that LF is a risk factor for different neurodegenerative disorders, one may expect higher incidences of neurodegenerative disorders with the increased levels of the risk factor (in this case LF). </plain></SENT>
<SENT sid="238" pm="."><plain>However, although age is also one of the strongest risk factors for late-onset neurodegenerative disorders, the normalized incidence of each entity (perhaps with the exception of AD) peaks at certain age range, from which it starts to decay. </plain></SENT>
<SENT sid="239" pm="."><plain>This apparent disagreement between a continuously increasing buildup of LF deposits as a risk factor and the variable age-specific peak incidence of diverse neurodegenerative disorders (de Pedro-Cuesta et al., 2015) is similar to other pathognomonic protein deposits. </plain></SENT>
<SENT sid="240" pm="."><plain>This could be explained either by a subclinical expression of LF deposits (vs. the clinical definition of incidence counts) or by more complex phenomena associated with a ceiling effect, above which the LF levels are already irrelevant. </plain></SENT>
</text></p><p><text><SENT sid="241" pm="."><plain>In line with the work from Giaccone and collaborators that discussed the potential pathogenic role of LF in AD (Giaccone et al., 2011), we propose that LF is one relevant effector of aging that represents a risk factor (or more properly, a risk modifier) for neurodegenerative disorders. </plain></SENT>
<SENT sid="242" pm="."><plain>In the context of our previous works, LF fits well with the concept of driver (defined as “neither protein/gene nor entity-specific features identifiable in the clinical and general epidemiology of neurodegenerative diseases as potential footprints of templating/spread/transfer mechanisms”) (de Pedro-Cuesta et al., 2016a). </plain></SENT>
<SENT sid="243" pm="."><plain>This transversal approach provides a unified view of LF pathological role in neurodegeneration for genetic (neuronal ceroid lipofuscinosis, and others) and sporadic neurodegenerative disorders with specific age-at-onset related patterns (de Pedro-Cuesta et al., 2016b). </plain></SENT>
<SENT sid="244" pm="."><plain>In conclusion, the relentless accumulation of LF is clearly associated to aging, but as we have reviewed herein, increasing evidence suggest that LF formation leads to neuropathology exacerbation by different mechanisms (see Figure 2). </plain></SENT>
<SENT sid="245" pm="."><plain>Further studies to determine whether LF accumulation itself, both within the neuronal cell and in the brain parenchyma, is contributing to neuronal loss and disease are needed. </plain></SENT>
<SENT sid="246" pm="."><plain>Proof-of-concept studies in mouse models aiming at specifically clearing existing LF deposits in NCLs may help to elucidate the role of LF and guide new therapeutic approaches for neurodegenerative disorders. </plain></SENT>
</text></p></sec></SecTag><SecTag type="AUTH_CONT"><sec id="s8"><title><text><SENT sid="247" pm="."><plain>Author contributions </plain></SENT>
</text></title><p><text><SENT sid="248" pm="."><plain>All authors participated in the conception and aims of the review. </plain></SENT>
<SENT sid="249" pm="."><plain>AM-G, AK, and OC participated in the literature search, and analysis of references, participated in the experimental acquisition of images for Figure 1, wrote sections of the manuscript. </plain></SENT>
<SENT sid="250" pm="."><plain>MM performed the critical revision of the article. </plain></SENT>
<SENT sid="251" pm="."><plain>MC wrote the first draft of the manuscript. </plain></SENT>
<SENT sid="252" pm="."><plain>All authors contributed to manuscript revision, read and approved the submitted version. </plain></SENT>
</text></p><sec><title><text><SENT sid="253" pm="."><plain>Conflict of interest statement </plain></SENT>
</text></title><p><text><SENT sid="254" pm="."><plain>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. </plain></SENT>
</text></p></sec></sec></SecTag></body><back><fn-group><SecTag type="ACK_FUND"><fn fn-type="financial-disclosure"><p><text4fund><text><SENT sid="255" pm="."><plain>Funding. This work was supported by grant SA1F2016-78603-R from Spanish Ministry of Economy, Industry and Competitiveness (MINECO) to MM and MC, the National Programme for the Promotion of Talent and its Employability from MINECO (AM-G), and the Spanish CIBERNED network (OC, MM, MC). </plain></SENT>
</text></text4fund></p></fn></SecTag></fn-group><SecTag type="REF"><ref-list><title>References</title><ref id="B1"><text><SENT sid="256" pm="."><plain>Abd El MohsenM. </plain></SENT>
<SENT sid="257" pm="."><plain>M.IravaniM. </plain></SENT>
<SENT sid="258" pm="."><plain>M.SpencerJ. </plain></SENT>
<SENT sid="259" pm="."><plain>P. </plain></SENT>
<SENT sid="260" pm="."><plain>E.RoseS.FahimA. </plain></SENT>
<SENT sid="261" pm="."><plain>T.MotawiT. </plain></SENT>
<SENT sid="262" pm="."><plain>M. </plain></SENT>
<SENT sid="263" pm="."><plain>K.. </plain></SENT>
<SENT sid="264" pm="."><plain>(2005). Age-associated changes in protein oxidation and proteasome activities in rat brain: modulation by antioxidants. Biochem. </plain></SENT>
<SENT sid="265" pm="."><plain>Biophys. </plain></SENT>
<SENT sid="266" pm="."><plain>Res. </plain></SENT>
<SENT sid="267" pm="."><plain>Commun. 336, 386–391. 10.1016/j.bbrc.2005.07.201<?supplied-pmid 16139799?>16139799 </plain></SENT>
</text></ref><ref id="B2"><text><SENT sid="268" pm="."><plain>AdlerL.BoyerN. </plain></SENT>
<SENT sid="269" pm="."><plain>P.ChenC.AblonczyZ.CrouchR. </plain></SENT>
<SENT sid="270" pm="."><plain>K.KoutalosY. (2015). The 11-cis retinal origins of lipofuscin in the retina. Prog. </plain></SENT>
<SENT sid="271" pm="."><plain>Mol. </plain></SENT>
<SENT sid="272" pm="."><plain>Biol. </plain></SENT>
<SENT sid="273" pm="."><plain>Transl. </plain></SENT>
<SENT sid="274" pm="."><plain>Sci. 134, e1–e12. 10.1016/bs.pmbts.2015.07.022<?supplied-pmid 26310175?>26310175 </plain></SENT>
</text></ref><ref id="B3"><text><SENT sid="275" pm="."><plain>AlvarezE. </plain></SENT>
<SENT sid="276" pm="."><plain>O.BeauquisJ.RevsinY.BanzanA. </plain></SENT>
<SENT sid="277" pm="."><plain>M.RoigP.De NicolaA. </plain></SENT>
<SENT sid="278" pm="."><plain>F.. </plain></SENT>
<SENT sid="279" pm="."><plain>(2009). Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behav. </plain></SENT>
<SENT sid="280" pm="."><plain>Brain Res. 198, 224–230. 10.1016/j.bbr.2008.11.001<?supplied-pmid 19041902?>19041902 </plain></SENT>
</text></ref><ref id="B4"><text><SENT sid="281" pm="."><plain>AnH.StatsyukA. </plain></SENT>
<SENT sid="282" pm="."><plain>V. (2015). An inhibitor of ubiquitin conjugation and aggresome formation. Chem. </plain></SENT>
<SENT sid="283" pm="."><plain>Sci. 6, 5235–5245. 10.1039/c5sc01351h<?supplied-pmid 28717502?>28717502 </plain></SENT>
</text></ref><ref id="B5"><text><SENT sid="284" pm="."><plain>AtkinsK.DasguptaA.ChenK.-H.MewburnJ.ArcherS. </plain></SENT>
<SENT sid="285" pm="."><plain>L. (2016). The role of Drp1 adaptor proteins MiD49 and MiD51 in mitochondrial fission: implications for human disease. Clin. </plain></SENT>
<SENT sid="286" pm="."><plain>Sci. 130, 1861–1874. 10.1042/CS20160030<?supplied-pmid 27660309?>27660309 </plain></SENT>
</text></ref><ref id="B6"><text><SENT sid="287" pm="."><plain>BandelloF.SacconiR.QuerquesL.CorbelliE.CicinelliM. </plain></SENT>
<SENT sid="288" pm="."><plain>V.QuerquesG. (2017). Recent advances in the management of dry age-related macular degeneration: a review. F1000Research 6:245. 10.12688/f1000research.10664.1<?supplied-pmid 28529701?>28529701 </plain></SENT>
</text></ref><ref id="B7"><text><SENT sid="289" pm="."><plain>BenavidesS. </plain></SENT>
<SENT sid="290" pm="."><plain>H.MonserratA. </plain></SENT>
<SENT sid="291" pm="."><plain>J.FariñaS.PortaE. </plain></SENT>
<SENT sid="292" pm="."><plain>A. (2002). Sequential histochemical studies of neuronal lipofuscin in human cerebral cortex from the first to the ninth decade of life. Arch. </plain></SENT>
<SENT sid="293" pm="."><plain>Gerontol. </plain></SENT>
<SENT sid="294" pm="."><plain>Geriatr. 34, 219–231. 10.1016/S0167-4943(01)00223-0<?supplied-pmid 14764325?>14764325 </plain></SENT>
</text></ref><ref id="B8"><text><SENT sid="295" pm="."><plain>BerkovicS. </plain></SENT>
<SENT sid="296" pm="."><plain>F.StaropoliJ. </plain></SENT>
<SENT sid="297" pm="."><plain>F.CarpenterS.OliverK. </plain></SENT>
<SENT sid="298" pm="."><plain>L.KmochS.AndersonG. </plain></SENT>
<SENT sid="299" pm="."><plain>W.. </plain></SENT>
<SENT sid="300" pm="."><plain>(2016). Diagnosis and misdiagnosis of adult neuronal ceroid lipofuscinosis (Kufs disease). Neurology 87, 579–584. 10.1212/WNL.0000000000002943<?supplied-pmid 27412140?>27412140 </plain></SENT>
</text></ref><ref id="B9"><text><SENT sid="301" pm="."><plain>BorgesM. </plain></SENT>
<SENT sid="302" pm="."><plain>M.Paula-BarbosaM. </plain></SENT>
<SENT sid="303" pm="."><plain>M.VolkB. (1986). Chronic alcohol consumption induces lipofuscin deposition in the rat hippocampus. Neurobiol. </plain></SENT>
<SENT sid="304" pm="."><plain>Aging 7, 347–355. 10.1016/0197-4580(86)90161-2<?supplied-pmid 3785534?>3785534 </plain></SENT>
</text></ref><ref id="B10"><text><SENT sid="305" pm="."><plain>BoultonM. </plain></SENT>
<SENT sid="306" pm="."><plain>E. (2014). Studying melanin and lipofuscin in RPE cell culture models. Exp. </plain></SENT>
<SENT sid="307" pm="."><plain>Eye Res. 126, 61–67. 10.1016/j.exer.2014.01.016<?supplied-pmid 25152361?>25152361 </plain></SENT>
</text></ref><ref id="B11"><text><SENT sid="308" pm="."><plain>BraakE.GriffingK.AraiK.BohlJ.BratzkeH.BraakH. (1999). Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? Eur. </plain></SENT>
<SENT sid="310" pm="."><plain>Arch. </plain></SENT>
<SENT sid="311" pm="."><plain>Psychiatry Clin. </plain></SENT>
<SENT sid="312" pm="."><plain>Neurosci. 249(Suppl. </plain></SENT>
<SENT sid="313" pm="."><plain>3), 14–22. <?supplied-pmid 10654095?>10654095 </plain></SENT>
</text></ref><ref id="B12"><text><SENT sid="314" pm="."><plain>BraakE.Sandmann-KeilD.RübU.GaiW. </plain></SENT>
<SENT sid="315" pm="."><plain>P.de VosR. </plain></SENT>
<SENT sid="316" pm="."><plain>A.SteurE. </plain></SENT>
<SENT sid="317" pm="."><plain>N.. </plain></SENT>
<SENT sid="318" pm="."><plain>(2001). Alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei. Acta Neuropathol. 101, 195–201. 10.1007/s004010000247<?supplied-pmid 11307617?>11307617 </plain></SENT>
</text></ref><ref id="B13"><text><SENT sid="319" pm="."><plain>BraakH.BraakE. (1992). Allocortical involvement in Huntington's disease. Neuropathol. </plain></SENT>
<SENT sid="320" pm="."><plain>Appl. </plain></SENT>
<SENT sid="321" pm="."><plain>Neurobiol. 18, 539–547. <?supplied-pmid 1488086?>1488086 </plain></SENT>
</text></ref><ref id="B14"><text><SENT sid="322" pm="."><plain>BraakH.BraakE. (1998). Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural Transm. </plain></SENT>
<SENT sid="324" pm="."><plain>Suppl. 53, 127–140. <?supplied-pmid 9700651?>9700651 </plain></SENT>
</text></ref><ref id="B15"><text><SENT sid="325" pm="."><plain>BraakH.Del TrediciK.RübU.de VosR. </plain></SENT>
<SENT sid="326" pm="."><plain>A. </plain></SENT>
<SENT sid="327" pm="."><plain>I.Jansen SteurE. </plain></SENT>
<SENT sid="328" pm="."><plain>N. </plain></SENT>
<SENT sid="329" pm="."><plain>H.BraakE. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. </plain></SENT>
<SENT sid="330" pm="."><plain>Aging 24, 197–211. 10.1016/S0197-4580(02)00065-9<?supplied-pmid 12498954?>12498954 </plain></SENT>
</text></ref><ref id="B16"><text><SENT sid="331" pm="."><plain>BraakH.ThalD. </plain></SENT>
<SENT sid="332" pm="."><plain>R.GhebremedhinE.Del TrediciK. (2011). Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J. Neuropathol. </plain></SENT>
<SENT sid="334" pm="."><plain>Exp. </plain></SENT>
<SENT sid="335" pm="."><plain>Neurol. 70, 960–969. 10.1097/NEN.0b013e318232a379<?supplied-pmid 22002422?>22002422 </plain></SENT>
</text></ref><ref id="B17"><text><SENT sid="336" pm="."><plain>BrunkU. </plain></SENT>
<SENT sid="337" pm="."><plain>T.TermanA. (2002). Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic. </plain></SENT>
<SENT sid="338" pm="."><plain>Biol. </plain></SENT>
<SENT sid="339" pm="."><plain>Med. 33, 611–619. 10.1016/S0891-5849(02)00959-0<?supplied-pmid 12208347?>12208347 </plain></SENT>
</text></ref><ref id="B18"><text><SENT sid="340" pm="."><plain>CataldoA. </plain></SENT>
<SENT sid="341" pm="."><plain>M.HamiltonD. </plain></SENT>
<SENT sid="342" pm="."><plain>J.NixonR. </plain></SENT>
<SENT sid="343" pm="."><plain>A. (1994). Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res. 640, 68–80. 10.1016/0006-8993(94)91858-9<?supplied-pmid 8004466?>8004466 </plain></SENT>
</text></ref><ref id="B19"><text><SENT sid="344" pm="."><plain>CaveC.ParkS.RodriguezM.NakamuraM.HokeA.PletnikovM.. </plain></SENT>
<SENT sid="345" pm="."><plain>(2017). GDE2 is essential for neuronal survival in the postnatal mammalian spinal cord. Mol. </plain></SENT>
<SENT sid="346" pm="."><plain>Neurodegener. 12:8. 10.1186/s13024-017-0148-1<?supplied-pmid 28103900?>28103900 </plain></SENT>
</text></ref><ref id="B20"><text><SENT sid="347" pm="."><plain>ChmátalováZ.VyhnálekM.LaczóJ.HortJ.SkoumalováA. (2016). Analysis of lipophilic fluorescent products in blood of Alzheimer's disease patients. J. Cell. </plain></SENT>
<SENT sid="349" pm="."><plain>Mol. </plain></SENT>
<SENT sid="350" pm="."><plain>Med. 20, 1367–1372. 10.1111/jcmm.12824<?supplied-pmid 26991927?>26991927 </plain></SENT>
</text></ref><ref id="B21"><text><SENT sid="351" pm="."><plain>Dalle-DonneI.RossiR.ColomboR.GiustariniD.MilzaniA. (2006). Biomarkers of oxidative damage in human disease. Clin. </plain></SENT>
<SENT sid="352" pm="."><plain>Chem. 52, 601–623. 10.1373/clinchem.2005.061408<?supplied-pmid 16484333?>16484333 </plain></SENT>
</text></ref><ref id="B22"><text><SENT sid="353" pm="."><plain>DaviesK. </plain></SENT>
<SENT sid="354" pm="."><plain>J. </plain></SENT>
<SENT sid="355" pm="."><plain>A. (2014). What goes wrong with Lon in ageing? Free Radic. </plain></SENT>
<SENT sid="356" pm="."><plain>Biol. </plain></SENT>
<SENT sid="357" pm="."><plain>Med. 75(Suppl. </plain></SENT>
<SENT sid="358" pm="."><plain>1):S6. 10.1016/j.freeradbiomed.2014.10.840<?supplied-pmid 26461412?>26461412 </plain></SENT>
</text></ref><ref id="B23"><text><SENT sid="359" pm="."><plain>DaviesS. </plain></SENT>
<SENT sid="360" pm="."><plain>W.TurmaineM.CozensB. </plain></SENT>
<SENT sid="361" pm="."><plain>A.DiFigliaM.SharpA. </plain></SENT>
<SENT sid="362" pm="."><plain>H.RossC. </plain></SENT>
<SENT sid="363" pm="."><plain>A.. </plain></SENT>
<SENT sid="364" pm="."><plain>(1997). Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537–548. 10.1016/S0092-8674(00)80513-9<?supplied-pmid 9267033?>9267033 </plain></SENT>
</text></ref><ref id="B24"><text><SENT sid="365" pm="."><plain>DrachL. </plain></SENT>
<SENT sid="366" pm="."><plain>M.BohlJ.WachS.SchloteW.GoebelH. </plain></SENT>
<SENT sid="367" pm="."><plain>H. (1998). Reduced intraneurona lipofuscin content in dementia with Lewy bodies compared with Alzheimer's disease and controls. Dement. </plain></SENT>
<SENT sid="368" pm="."><plain>Geriatr. </plain></SENT>
<SENT sid="369" pm="."><plain>Cogn. </plain></SENT>
<SENT sid="370" pm="."><plain>Disord. 9, 1–5. 10.1159/000017013<?supplied-pmid 9469257?>9469257 </plain></SENT>
</text></ref><ref id="B25"><text><SENT sid="371" pm="."><plain>DaviesS. </plain></SENT>
<SENT sid="372" pm="."><plain>W.TurmaineM.CozensB. </plain></SENT>
<SENT sid="373" pm="."><plain>A.RazaA. </plain></SENT>
<SENT sid="374" pm="."><plain>S.MahalA.MangiariniL.. </plain></SENT>
<SENT sid="375" pm="."><plain>(1999). From neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington's disease. Philos. </plain></SENT>
<SENT sid="376" pm="."><plain>Trans. </plain></SENT>
<SENT sid="377" pm="."><plain>R. </plain></SENT>
<SENT sid="378" pm="."><plain>Soc. </plain></SENT>
<SENT sid="379" pm="."><plain>B Biol. </plain></SENT>
<SENT sid="380" pm="."><plain>Sci. 354, 981–989. <?supplied-pmid 10434295?>10434295 </plain></SENT>
</text></ref><ref id="B26"><text><SENT sid="381" pm="."><plain>de CastroJ. </plain></SENT>
<SENT sid="382" pm="."><plain>P. </plain></SENT>
<SENT sid="383" pm="."><plain>F.MullinsR. </plain></SENT>
<SENT sid="384" pm="."><plain>F.ManeaA. </plain></SENT>
<SENT sid="385" pm="."><plain>M.HernandezJ.WallenT.KuehnM. </plain></SENT>
<SENT sid="386" pm="."><plain>H. (2013). Lipofuscin in human glaucomatous optic nerves. Exp. </plain></SENT>
<SENT sid="387" pm="."><plain>Eye Res. 111, 61–66. 10.1016/j.exer.2013.03.01923567206 </plain></SENT>
</text></ref><ref id="B27"><text><SENT sid="388" pm="."><plain>Del TrediciK.BraakH. (2016). Review: sporadic Parkinson's disease: development and distribution of α-synuclein pathology. Neuropathol. </plain></SENT>
<SENT sid="389" pm="."><plain>Appl. </plain></SENT>
<SENT sid="390" pm="."><plain>Neurobiol. 42, 33–50. 10.1111/nan.12298<?supplied-pmid 26662475?>26662475 </plain></SENT>
</text></ref><ref id="B28"><text><SENT sid="391" pm="."><plain>de Pedro-CuestaJ.Martínez-MartínP.RábanoA.Alcalde-CaberoE.José García LópezF.Almazán-IslaJ.. </plain></SENT>
<SENT sid="392" pm="."><plain>(2016a). Drivers: a biologically contextualized, cross-inferential view of the epidemiology of neurodegenerative disorders. J. Alzheimers. </plain></SENT>
<SENT sid="394" pm="."><plain>Dis. 51, 1003–1022. 10.3233/JAD-150884<?supplied-pmid 26923014?>26923014 </plain></SENT>
</text></ref><ref id="B29"><text><SENT sid="395" pm="."><plain>de Pedro-CuestaJ.Martínez-MartínP.RábanoA.Ruiz-TovarM.Alcalde-CaberoE.CaleroM. (2016b). Etiologic framework for the study of neurodegenerative disorders as well as vascular and metabolic comorbidities on the grounds of shared epidemiologic and biologic features. Front. </plain></SENT>
<SENT sid="396" pm="."><plain>Aging Neurosci. 8:138. 10.3389/fnagi.2016.00138<?supplied-pmid 27378910?>27378910 </plain></SENT>
</text></ref><ref id="B30"><text><SENT sid="397" pm="."><plain>de Pedro-CuestaJ.RábanoA.Martínez-MartínP.Ruiz-TovarM.Alcalde-CaberoE.Almazán-IslaJ. (2015). Comparative incidence of conformational, neurodegenerative disorders. PLoS ONE 10:e0137342 10.1371/journal.pone.013734226335347 </plain></SENT>
</text></ref><ref id="B31"><text><SENT sid="398" pm="."><plain>DlugosC. </plain></SENT>
<SENT sid="399" pm="."><plain>A. (2015). Ethanol-induced alterations in purkinje neuron dendrites in adult and aging rats: a review. Cerebellum Lond. </plain></SENT>
<SENT sid="400" pm="."><plain>Engl. 14, 466–473. 10.1007/s12311-014-0636-6<?supplied-pmid 25648753?>25648753 </plain></SENT>
</text></ref><ref id="B32"><text><SENT sid="401" pm="."><plain>DoubleK. </plain></SENT>
<SENT sid="402" pm="."><plain>L.DedovV. </plain></SENT>
<SENT sid="403" pm="."><plain>N.FedorowH.KettleE.HallidayG. </plain></SENT>
<SENT sid="404" pm="."><plain>M.GarnerB.. </plain></SENT>
<SENT sid="405" pm="."><plain>(2008). The comparative biology of neuromelanin and lipofuscin in the human brain. Cell. </plain></SENT>
<SENT sid="406" pm="."><plain>Mol. </plain></SENT>
<SENT sid="407" pm="."><plain>Life Sci. 65, 1669–1682. 10.1007/s00018-008-7581-9<?supplied-pmid 18278576?>18278576 </plain></SENT>
</text></ref><ref id="B33"><text><SENT sid="408" pm="."><plain>EzakiJ.WolfeL. </plain></SENT>
<SENT sid="409" pm="."><plain>S.KominamiE. (1995). Defect of proteolysis of mitochondrial ATP synthase subunit C in neuronal ceroid lipofuscinosis. Gerontology 41(Suppl. </plain></SENT>
<SENT sid="410" pm="."><plain>2), 259–269. 10.1159/000213748<?supplied-pmid 8821337?>8821337 </plain></SENT>
</text></ref><ref id="B34"><text><SENT sid="411" pm="."><plain>FeldmanT. </plain></SENT>
<SENT sid="412" pm="."><plain>B.YakovlevaM. </plain></SENT>
<SENT sid="413" pm="."><plain>A.ArbukhanovaP. </plain></SENT>
<SENT sid="414" pm="."><plain>M.BorzenokS. </plain></SENT>
<SENT sid="415" pm="."><plain>A.KononikhinA. </plain></SENT>
<SENT sid="416" pm="."><plain>S.PopovI. </plain></SENT>
<SENT sid="417" pm="."><plain>A.. </plain></SENT>
<SENT sid="418" pm="."><plain>(2015). Changes in spectral properties and composition of lipofuscin fluorophores from human-retinal-pigment epithelium with age and pathology. Anal. </plain></SENT>
<SENT sid="419" pm="."><plain>Bioanal. </plain></SENT>
<SENT sid="420" pm="."><plain>Chem. 407, 1075–1088. 10.1007/s00216-014-8353-z<?supplied-pmid 25471291?>25471291 </plain></SENT>
</text></ref><ref id="B35"><text><SENT sid="421" pm="."><plain>FerrerI.MartinezA.BlancoR.DalfóE.CarmonaM. (2011). Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. J. Neural Transm. 118, 821–839. 10.1007/s00702-010-0482-8<?supplied-pmid 20862500?>20862500 </plain></SENT>
</text></ref><ref id="B36"><text><SENT sid="423" pm="."><plain>FirlagM.KamaszewskiM.GacaK.BałasinskaB. (2013). Age-related changes in the central nervous system in selected domestic mammals and primates. Postepy Hig. </plain></SENT>
<SENT sid="424" pm="."><plain>Med. </plain></SENT>
<SENT sid="425" pm="."><plain>Doswiadczalnej Online 67, 269–275. 10.5604/17322693.1044490<?supplied-pmid 23619226?>23619226 </plain></SENT>
</text></ref><ref id="B37"><text><SENT sid="426" pm="."><plain>FolchJ.LeesM.StanleyG. </plain></SENT>
<SENT sid="427" pm="."><plain>H. </plain></SENT>
<SENT sid="428" pm="."><plain>S. (1957). A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. </plain></SENT>
<SENT sid="430" pm="."><plain>Chem. 226, 497–509. <?supplied-pmid 13428781?>13428781 </plain></SENT>
</text></ref><ref id="B38"><text><SENT sid="431" pm="."><plain>FortunJ.DunnW. </plain></SENT>
<SENT sid="432" pm="."><plain>A.JoyS.LiJ.NotterpekL. (2003). Emerging role for autophagy in the removal of aggresomes in schwann cells. J. Neurosci. 23, 10672–10680. 10.1523/JNEUROSCI.23-33-10672.2003<?supplied-pmid 14627652?>14627652 </plain></SENT>
</text></ref><ref id="B39"><text><SENT sid="434" pm="."><plain>FortunJ.LiJ.GoJ.FenstermakerA.FletcherB. </plain></SENT>
<SENT sid="435" pm="."><plain>S.NotterpekL. (2005). Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model. J. Neurochem. 92, 1531–1541. 10.1111/j.1471-4159.2004.02987.x<?supplied-pmid 15748170?>15748170 </plain></SENT>
</text></ref><ref id="B40"><text><SENT sid="437" pm="."><plain>FrolovaM. </plain></SENT>
<SENT sid="438" pm="."><plain>S.SurinA. </plain></SENT>
<SENT sid="439" pm="."><plain>M.BraslavskiA. </plain></SENT>
<SENT sid="440" pm="."><plain>V.VekshinN. </plain></SENT>
<SENT sid="441" pm="."><plain>L. (2015). Degradation of mitochondria to lipofuscin upon heating and illumination. Biophysics 60, 934–939. 10.1134/S0006350915060081<?supplied-pmid 26841506?>26841506 </plain></SENT>
</text></ref><ref id="B41"><text><SENT sid="442" pm="."><plain>GiacconeG.OrsiL.CupidiC.TagliaviniF. (2011). Lipofuscin hypothesis of Alzheimer's disease. Dement. </plain></SENT>
<SENT sid="443" pm="."><plain>Geriatr. </plain></SENT>
<SENT sid="444" pm="."><plain>Cogn. </plain></SENT>
<SENT sid="445" pm="."><plain>Disord. </plain></SENT>
<SENT sid="446" pm="."><plain>Extra 1, 292–296. 10.1159/000329544<?supplied-pmid 22545040?>22545040 </plain></SENT>
</text></ref><ref id="B42"><text><SENT sid="447" pm="."><plain>GoebelH. </plain></SENT>
<SENT sid="448" pm="."><plain>H.HeipertzR.ScholzW.IqbalK.Tellez-NagelI. (1978). Juvenile Huntington chorea: clinical, ultrastructural, and biochemical studies. Neurology 28, 23–31. 10.1212/WNL.28.1.23<?supplied-pmid 145549?>145549 </plain></SENT>
</text></ref><ref id="B43"><text><SENT sid="449" pm="."><plain>GoldsteinB. </plain></SENT>
<SENT sid="450" pm="."><plain>D.McDonaghE. </plain></SENT>
<SENT sid="451" pm="."><plain>M. (1976). Spectrofluorescent detection of in vivo red cell lipid peroxidation in patients treated with diaminodiphenylsulfone. J. Clin. </plain></SENT>
<SENT sid="453" pm="."><plain>Invest. 57, 1302–1307. 10.1172/JCI108398<?supplied-pmid 1262473?>1262473 </plain></SENT>
</text></ref><ref id="B44"><text><SENT sid="454" pm="."><plain>González-ScaranoF.BaltuchG. (1999). Microglia as mediators of inflammatory and degenerative diseases. Annu. </plain></SENT>
<SENT sid="455" pm="."><plain>Rev. </plain></SENT>
<SENT sid="456" pm="."><plain>Neurosci. 22, 219–240. 10.1146/annurev.neuro.22.1.219<?supplied-pmid 10202538?>10202538 </plain></SENT>
</text></ref><ref id="B45"><text><SENT sid="457" pm="."><plain>GrubmanA.PollariE.DuncanC.CaragounisA.BlomT.VolitakisI.. </plain></SENT>
<SENT sid="458" pm="."><plain>(2014). Deregulation of biometal homeostasis: the missing link for neuronal ceroid lipofuscinoses? Met. </plain></SENT>
<SENT sid="459" pm="."><plain>Integr. </plain></SENT>
<SENT sid="460" pm="."><plain>Biometal Sci. 6, 932–943. 10.1039/C4MT00032C<?supplied-pmid 24804307?>24804307 </plain></SENT>
</text></ref><ref id="B46"><text><SENT sid="461" pm="."><plain>GruneT.JungT.MerkerK.DaviesK. </plain></SENT>
<SENT sid="462" pm="."><plain>J. (2004). Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and “aggresomes” during oxidative stress, aging, and disease. Int. </plain></SENT>
<SENT sid="463" pm="."><plain>J. </plain></SENT>
<SENT sid="464" pm="."><plain>Biochem. </plain></SENT>
<SENT sid="465" pm="."><plain>Cell Biol. 36, 2519–2530. 10.1016/j.biocel.2004.04.020<?supplied-pmid 15325589?>15325589 </plain></SENT>
</text></ref><ref id="B47"><text><SENT sid="466" pm="."><plain>GruneT.ShringarpureR.SitteN.DaviesK. (2001). Age-related changes in protein oxidation and proteolysis in mammalian cells. J. Gerontol. </plain></SENT>
<SENT sid="468" pm="."><plain>A Biol. </plain></SENT>
<SENT sid="469" pm="."><plain>Sci. </plain></SENT>
<SENT sid="470" pm="."><plain>Med. </plain></SENT>
<SENT sid="471" pm="."><plain>Sci. 56, B459–B467. 10.1093/gerona/56.11.B459<?supplied-pmid 11682566?>11682566 </plain></SENT>
</text></ref><ref id="B48"><text><SENT sid="472" pm="."><plain>HaraT.NakamuraK.MatsuiM.YamamotoA.NakaharaY.Suzuki-MigishimaR.. </plain></SENT>
<SENT sid="473" pm="."><plain>(2006). Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885–889. 10.1038/nature04724<?supplied-pmid 16625204?>16625204 </plain></SENT>
</text></ref><ref id="B49"><text><SENT sid="474" pm="."><plain>Hashemzadeh-BonehiL.PhillipsR. </plain></SENT>
<SENT sid="475" pm="."><plain>G.CairnsN. </plain></SENT>
<SENT sid="476" pm="."><plain>J.MosahebS.ThorpeJ. </plain></SENT>
<SENT sid="477" pm="."><plain>R. (2006). Pin1 protein associates with neuronal lipofuscin: potential consequences in age-related neurodegeneration. Exp. </plain></SENT>
<SENT sid="478" pm="."><plain>Neurol. 199, 328–338. 10.1016/j.expneurol.2005.12.030<?supplied-pmid 16480979?>16480979 </plain></SENT>
</text></ref><ref id="B50"><text><SENT sid="479" pm="."><plain>HebbarS.KhandelwalA.JayashreeR.HindleS. </plain></SENT>
<SENT sid="480" pm="."><plain>J.ChiangY. </plain></SENT>
<SENT sid="481" pm="."><plain>N.YewJ. </plain></SENT>
<SENT sid="482" pm="."><plain>Y.. </plain></SENT>
<SENT sid="483" pm="."><plain>(2017). Lipid metabolic perturbation is an early-onset phenotype in adult spinster mutants: a Drosophila model for lysosomal storage disorders. Mol. </plain></SENT>
<SENT sid="484" pm="."><plain>Biol. </plain></SENT>
<SENT sid="485" pm="."><plain>Cell 28, 3728–3740. 10.1091/mbc.e16-09-0674<?supplied-pmid 29046397?>29046397 </plain></SENT>
</text></ref><ref id="B51"><text><SENT sid="486" pm="."><plain>HöhnA.GruneT. (2013). Lipofuscin: formation, effects and role of macroautophagy. Redox Biol. 1, 140–144. 10.1016/j.redox.2013.01.006<?supplied-pmid 24024146?>24024146 </plain></SENT>
</text></ref><ref id="B52"><text><SENT sid="487" pm="."><plain>HöhnA.JungT.GrimmS.CatalgolB.WeberD.GruneT. (2011). Lipofuscin inhibits the proteasome by binding to surface motifs. Free Radic. </plain></SENT>
<SENT sid="488" pm="."><plain>Biol. </plain></SENT>
<SENT sid="489" pm="."><plain>Med. 50, 585–591. 10.1016/j.freeradbiomed.2010.12.011<?supplied-pmid 21167934?>21167934 </plain></SENT>
</text></ref><ref id="B53"><text><SENT sid="490" pm="."><plain>HöhnA.JungT.GrimmS.GruneT. (2010). Lipofuscin-bound iron is a major intracellular source of oxidants: role in senescent cells. Free Radic. </plain></SENT>
<SENT sid="491" pm="."><plain>Biol. </plain></SENT>
<SENT sid="492" pm="."><plain>Med. 48, 1100–1108. 10.1016/j.freeradbiomed.2010.01.030<?supplied-pmid 20116426?>20116426 </plain></SENT>
</text></ref><ref id="B54"><text><SENT sid="493" pm="."><plain>HorieK.MiyataT.YasudaT.TakedaA.YasudaY.MaedaK.. </plain></SENT>
<SENT sid="494" pm="."><plain>(1997). Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. Biochem. </plain></SENT>
<SENT sid="495" pm="."><plain>Biophys. </plain></SENT>
<SENT sid="496" pm="."><plain>Res. </plain></SENT>
<SENT sid="497" pm="."><plain>Commun. 236, 327–332. <?supplied-pmid 9240434?>9240434 </plain></SENT>
</text></ref><ref id="B55"><text><SENT sid="498" pm="."><plain>HungC.-W.ChenY.-C.HsiehW.-L.ChiouS.-H.KaoC.-L. (2010). Ageing and neurodegenerative diseases. Ageing Res. </plain></SENT>
<SENT sid="499" pm="."><plain>Rev. 9(Suppl), S36–S46. 10.1016/j.arr.2010.08.006<?supplied-pmid 20732460?>20732460 </plain></SENT>
</text></ref><ref id="B56"><text><SENT sid="500" pm="."><plain>JensenT.Holten-RossingH.SvendsenI. </plain></SENT>
<SENT sid="501" pm="."><plain>H.JacobsenC.VainerB. (2016). Quantitative analysis of myocardial tissue with digital autofluorescence microscopy. J. Pathol. </plain></SENT>
<SENT sid="503" pm="."><plain>Inform. 7:15. 10.4103/2153-3539.179908<?supplied-pmid 27141321?>27141321 </plain></SENT>
</text></ref><ref id="B57"><text><SENT sid="504" pm="."><plain>JollyR. </plain></SENT>
<SENT sid="505" pm="."><plain>D.DouglasB. </plain></SENT>
<SENT sid="506" pm="."><plain>V.DaveyP. </plain></SENT>
<SENT sid="507" pm="."><plain>M.RoiriJ. </plain></SENT>
<SENT sid="508" pm="."><plain>E. (1995). Lipofuscin in bovine muscle and brain: a model for studying age pigment. Gerontology 41(Suppl. </plain></SENT>
<SENT sid="509" pm="."><plain>2), 283–295. 10.1159/000213750<?supplied-pmid 8821339?>8821339 </plain></SENT>
</text></ref><ref id="B58"><text><SENT sid="510" pm="."><plain>JungH.LeeE. </plain></SENT>
<SENT sid="511" pm="."><plain>Y.LeeS. </plain></SENT>
<SENT sid="512" pm="."><plain>I. (1999). Age-related changes in ultrastructural features of cathepsin B- and D-containing neurons in rat cerebral cortex. Brain Res. 844, 43–54. 10.1016/S0006-8993(99)01888-0<?supplied-pmid 10536260?>10536260 </plain></SENT>
</text></ref><ref id="B59"><text><SENT sid="513" pm="."><plain>JungT.HöhnA.GruneT. (2010). Lipofuscin: detection and quantification by microscopic techniques, in Advanced Protocols in Oxidative Stress II, ed ArmstrongD. (Totowa, NJ: Humana Press), 173–193. </plain></SENT>
</text></ref><ref id="B60"><text><SENT sid="514" pm="."><plain>KasperD.Planells-CasesR.FuhrmannJ. </plain></SENT>
<SENT sid="515" pm="."><plain>C.ScheelO.ZeitzO.RuetherK.. </plain></SENT>
<SENT sid="516" pm="."><plain>(2005). Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J. 24, 1079–1091. 10.1038/sj.emboj.7600576<?supplied-pmid 15706348?>15706348 </plain></SENT>
</text></ref><ref id="B61"><text><SENT sid="517" pm="."><plain>KaushikS.CuervoA. </plain></SENT>
<SENT sid="518" pm="."><plain>M. (2012). Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol. 22, 407–417. 10.1016/j.tcb.2012.05.006<?supplied-pmid 22748206?>22748206 </plain></SENT>
</text></ref><ref id="B62"><text><SENT sid="519" pm="."><plain>KellerJ. </plain></SENT>
<SENT sid="520" pm="."><plain>N.DimayugaE.ChenQ.ThorpeJ.GeeJ.DingQ. (2004). Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int. </plain></SENT>
<SENT sid="521" pm="."><plain>J. </plain></SENT>
<SENT sid="522" pm="."><plain>Biochem. </plain></SENT>
<SENT sid="523" pm="."><plain>Cell Biol. 36, 2376–2391. 10.1016/j.biocel.2004.05.003<?supplied-pmid 15325579?>15325579 </plain></SENT>
</text></ref><ref id="B63"><text><SENT sid="524" pm="."><plain>KetternN.RogonC.LimmerA.SchildH.HöhfeldJ. (2011). The Hsc/Hsp70 co-chaperone network controls antigen aggregation and presentation during maturation of professional antigen presenting cells. PLoS ONE 6:e16398. 10.1371/journal.pone.0016398<?supplied-pmid 21283720?>21283720 </plain></SENT>
</text></ref><ref id="B64"><text><SENT sid="525" pm="."><plain>KleinZ. </plain></SENT>
<SENT sid="526" pm="."><plain>A.TakahashiH.MaM.StagiM.ZhouM.LamT. </plain></SENT>
<SENT sid="527" pm="."><plain>T.. </plain></SENT>
<SENT sid="528" pm="."><plain>(2017). Loss of TMEM106B ameliorates lysosomal and frontotemporal dementia-related phenotypes in progranulin-deficient mice. Neuron 95, 281.e6–296.e6. 10.1016/j.neuron.2017.06.026<?supplied-pmid 28728022?>28728022 </plain></SENT>
</text></ref><ref id="B65"><text><SENT sid="529" pm="."><plain>KohanR.CismondiI. </plain></SENT>
<SENT sid="530" pm="."><plain>A.Oller-RamirezA. </plain></SENT>
<SENT sid="531" pm="."><plain>M.GuelbertN.AnzoliniV. </plain></SENT>
<SENT sid="532" pm="."><plain>T.AlonsoG.. </plain></SENT>
<SENT sid="533" pm="."><plain>(2011). Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses. Curr. </plain></SENT>
<SENT sid="534" pm="."><plain>Pharm. </plain></SENT>
<SENT sid="535" pm="."><plain>Biotechnol. 12, 867–883. 10.2174/138920111795542633<?supplied-pmid 21235444?>21235444 </plain></SENT>
</text></ref><ref id="B66"><text><SENT sid="536" pm="."><plain>KoikeM.NakanishiH.SaftigP.EzakiJ.IsaharaK.OhsawaY.. </plain></SENT>
<SENT sid="537" pm="."><plain>(2000). Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J. Neurosci. </plain></SENT>
<SENT sid="539" pm="."><plain>Off. </plain></SENT>
<SENT sid="540" pm="."><plain>J. </plain></SENT>
<SENT sid="541" pm="."><plain>Soc. </plain></SENT>
<SENT sid="542" pm="."><plain>Neurosci. 20, 6898–6906. 10.1523/JNEUROSCI.20-18-06898.2000<?supplied-pmid 10995834?>10995834 </plain></SENT>
</text></ref><ref id="B67"><text><SENT sid="543" pm="."><plain>KönigJ.OttC.HugoM.JungT.BulteauA. </plain></SENT>
<SENT sid="544" pm="."><plain>L.GruneT.. </plain></SENT>
<SENT sid="545" pm="."><plain>(2017). Mitochondrial contribution to lipofuscin formation. Redox Biol. 11, 673–681. 10.1016/j.redox.2017.01.017<?supplied-pmid 28160744?>28160744 </plain></SENT>
</text></ref><ref id="B68"><text><SENT sid="546" pm="."><plain>KukullW. </plain></SENT>
<SENT sid="547" pm="."><plain>A.HigdonR.BowenJ. </plain></SENT>
<SENT sid="548" pm="."><plain>D.McCormickW. </plain></SENT>
<SENT sid="549" pm="."><plain>C.TeriL.SchellenbergG. </plain></SENT>
<SENT sid="550" pm="."><plain>D.. </plain></SENT>
<SENT sid="551" pm="."><plain>(2002). Dementia and Alzheimer disease incidence: a prospective cohort study. Arch. </plain></SENT>
<SENT sid="552" pm="."><plain>Neurol. 59, 1737–1746. 10.1001/archneur.59.11.1737<?supplied-pmid 12433261?>12433261 </plain></SENT>
</text></ref><ref id="B69"><text><SENT sid="553" pm="."><plain>KunA.González-CamachoF.HernándezS.Moreno-GarcíaA.CaleroO.CaleroM. (2018). Characterization of Amyloid-β Plaques and Autofluorescent Lipofuscin Aggregates in Alzheimer's Disease Brain: A Confocal Microscopy Approach, in Amyloid Proteins, eds. SigurdssonE. </plain></SENT>
<SENT sid="554" pm="."><plain>M.CaleroM.GassetM. (New York, NY: Springer New York), 497–512. 10.1007/978-1-4939-7816-8_31 </plain></SENT>
</text></ref><ref id="B70"><text><SENT sid="555" pm="."><plain>LambL. </plain></SENT>
<SENT sid="556" pm="."><plain>E.SimonJ. </plain></SENT>
<SENT sid="557" pm="."><plain>D. (2004). A2E: a component of ocular lipofuscin. Photochem. </plain></SENT>
<SENT sid="558" pm="."><plain>Photobiol. 79, 127–136. 10.1111/j.1751-1097.2004.tb00002.x<?supplied-pmid 15068025?>15068025 </plain></SENT>
</text></ref><ref id="B71"><text><SENT sid="559" pm="."><plain>LeiL.TzekovR.LiH.McDowellJ. </plain></SENT>
<SENT sid="560" pm="."><plain>H.GaoG.SmithW. </plain></SENT>
<SENT sid="561" pm="."><plain>C.. </plain></SENT>
<SENT sid="562" pm="."><plain>(2017). Inhibition or stimulation of autophagy affects early formation of lipofuscin-like autofluorescence in the retinal pigment epithelium cell. Int. </plain></SENT>
<SENT sid="563" pm="."><plain>J. </plain></SENT>
<SENT sid="564" pm="."><plain>Mol. </plain></SENT>
<SENT sid="565" pm="."><plain>Sci. 18:728. 10.3390/ijms18040728<?supplied-pmid 28353645?>28353645 </plain></SENT>
</text></ref><ref id="B72"><text><SENT sid="566" pm="."><plain>LevinS. </plain></SENT>
<SENT sid="567" pm="."><plain>W.BakerE. </plain></SENT>
<SENT sid="568" pm="."><plain>H.ZeinW. </plain></SENT>
<SENT sid="569" pm="."><plain>M.ZhangZ.QuezadoZ. </plain></SENT>
<SENT sid="570" pm="."><plain>M. </plain></SENT>
<SENT sid="571" pm="."><plain>N.MiaoN. (2014). Oral Cysteamine bitartrate and N-acetylcysteine combination for patients with infantile neuronal ceroid lipofuscinosis:a pilot study. Lancet Neurol. 13, 777–787. 10.1016/S1474-4422(14)70142-524997880 </plain></SENT>
</text></ref><ref id="B73"><text><SENT sid="572" pm="."><plain>LewandowskaE.KujawaM.JedrzejewskaA. (1994). Ethanol-induced changes in Purkinje cells of rat cerebellum. </plain></SENT>
<SENT sid="573" pm="."><plain>II. </plain></SENT>
<SENT sid="574" pm="."><plain>The ultrastructural changes after chronic ethanol intoxication. </plain></SENT>
<SENT sid="575" pm="."><plain>(Morphometric evaluation). Folia Neuropathol. 32, 61–64. <?supplied-pmid 7922104?>7922104 </plain></SENT>
</text></ref><ref id="B74"><text><SENT sid="576" pm="."><plain>López-OtínC.BlascoM. </plain></SENT>
<SENT sid="577" pm="."><plain>A.PartridgeL.SerranoM.KroemerG. (2013). The hallmarks of aging. Cell 153, 1194–1217. 10.1016/j.cell.2013.05.039<?supplied-pmid 23746838?>23746838 </plain></SENT>
</text></ref><ref id="B75"><text><SENT sid="578" pm="."><plain>LvZ.JiangH.XuH.SongN.XieJ. (2011). Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease. J. Neural Transm. 118, 361–369. 10.1007/s00702-010-0434-3<?supplied-pmid 20556443?>20556443 </plain></SENT>
</text></ref><ref id="B76"><text><SENT sid="580" pm="."><plain>MaccarinelliF.PaganiA.CozziA.CodazziF.Di GiacomoG.CapocciaS.. </plain></SENT>
<SENT sid="581" pm="."><plain>(2015). A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits. Neurobiol. </plain></SENT>
<SENT sid="582" pm="."><plain>Dis. 81, 119–133. 10.1016/j.nbd.2014.10.023<?supplied-pmid 25447222?>25447222 </plain></SENT>
</text></ref><ref id="B77"><text><SENT sid="583" pm="."><plain>MaxwellK. </plain></SENT>
<SENT sid="584" pm="."><plain>E.MatthewsT. </plain></SENT>
<SENT sid="585" pm="."><plain>R.SheehyM. </plain></SENT>
<SENT sid="586" pm="."><plain>R.BertelsenR. </plain></SENT>
<SENT sid="587" pm="."><plain>D.DerbyC. </plain></SENT>
<SENT sid="588" pm="."><plain>D. (2007). Neurolipofuscin is a measure of age in Panulirus argus, the Caribbean spiny lobster, in Florida. Biol. </plain></SENT>
<SENT sid="589" pm="."><plain>Bull. 213, 55–66. 10.2307/25066618<?supplied-pmid 17679720?>17679720 </plain></SENT>
</text></ref><ref id="B78"><text><SENT sid="590" pm="."><plain>MeredithG. </plain></SENT>
<SENT sid="591" pm="."><plain>E.TotterdellS.PetroskeE.Santa CruzK.CallisonR. </plain></SENT>
<SENT sid="592" pm="."><plain>C.LauY.-S. (2002). Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res. 956, 156–165. 10.1016/S0006-8993(02)03514-X<?supplied-pmid 12426058?>12426058 </plain></SENT>
</text></ref><ref id="B79"><text><SENT sid="593" pm="."><plain>MinkJ. </plain></SENT>
<SENT sid="594" pm="."><plain>W.AugustineE. </plain></SENT>
<SENT sid="595" pm="."><plain>F.AdamsH. </plain></SENT>
<SENT sid="596" pm="."><plain>R.MarshallF. </plain></SENT>
<SENT sid="597" pm="."><plain>J.KwonJ. </plain></SENT>
<SENT sid="598" pm="."><plain>M. (2013). Classification and natural history of the neuronal ceroid lipofuscinoses. J. Child Neurol. 28, 1101–1105. 10.1177/0883073813494268<?supplied-pmid 23838030?>23838030 </plain></SENT>
</text></ref><ref id="B80"><text><SENT sid="600" pm="."><plain>MizushimaN. (2007). Autophagy: process and function. Genes Dev. 21, 2861–2873. 10.1101/gad.1599207<?supplied-pmid 18006683?>18006683 </plain></SENT>
</text></ref><ref id="B81"><text><SENT sid="601" pm="."><plain>MizushimaN.YamamotoA.MatsuiM.YoshimoriT.OhsumiY. (2004). In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. </plain></SENT>
<SENT sid="602" pm="."><plain>Biol. </plain></SENT>
<SENT sid="603" pm="."><plain>Cell 15, 1101–1111. 10.1091/mbc.e03-09-0704<?supplied-pmid 14699058?>14699058 </plain></SENT>
</text></ref><ref id="B82"><text><SENT sid="604" pm="."><plain>MooreW. </plain></SENT>
<SENT sid="605" pm="."><plain>A.DaveyV. </plain></SENT>
<SENT sid="606" pm="."><plain>A.WeindruchR.WalfordR.IvyG. </plain></SENT>
<SENT sid="607" pm="."><plain>O. (1995). The effect of caloric restriction on lipofuscin accumulation in mouse brain with age. Gerontology 41, 173–186. 10.1159/000213741<?supplied-pmid 8821330?>8821330 </plain></SENT>
</text></ref><ref id="B83"><text><SENT sid="608" pm="."><plain>MorawskiM.BrücknerM. </plain></SENT>
<SENT sid="609" pm="."><plain>K.RiedererP.BrücknerG.ArendtT. (2004). Perineuronal nets potentially protect against oxidative stress. Exp. </plain></SENT>
<SENT sid="610" pm="."><plain>Neurol. 188, 309–315. 10.1016/j.expneurol.2004.04.017<?supplied-pmid 15246831?>15246831 </plain></SENT>
</text></ref><ref id="B84"><text><SENT sid="611" pm="."><plain>MoreiraP. </plain></SENT>
<SENT sid="612" pm="."><plain>I.CarvalhoC.ZhuX.SmithM. </plain></SENT>
<SENT sid="613" pm="."><plain>A.PerryG. (2010). Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochim. </plain></SENT>
<SENT sid="614" pm="."><plain>Biophys. </plain></SENT>
<SENT sid="615" pm="."><plain>Acta 1802, 2–10. 10.1016/j.bbadis.2009.10.006<?supplied-pmid 19853658?>19853658 </plain></SENT>
</text></ref><ref id="B85"><text><SENT sid="616" pm="."><plain>NakanoY.FujitaniK.KuriharaJ.RaganJ.Usui-AokiK.ShimodaL.. </plain></SENT>
<SENT sid="617" pm="."><plain>(2001). Mutations in the novel membrane protein spinster interfere with programmed cell death and cause neural degeneration in Drosophila melanogaster. Mol. </plain></SENT>
<SENT sid="618" pm="."><plain>Cell. </plain></SENT>
<SENT sid="619" pm="."><plain>Biol. 21, 3775–3788. 10.1128/MCB.21.11.3775-3788.2001<?supplied-pmid 11340170?>11340170 </plain></SENT>
</text></ref><ref id="B86"><text><SENT sid="620" pm="."><plain>NevermanN. </plain></SENT>
<SENT sid="621" pm="."><plain>J.BestH. </plain></SENT>
<SENT sid="622" pm="."><plain>L.HofmannS. </plain></SENT>
<SENT sid="623" pm="."><plain>L.HughesS. </plain></SENT>
<SENT sid="624" pm="."><plain>M. (2015). Experimental therapies in the neuronal ceroid lipofuscinoses. Biochim. </plain></SENT>
<SENT sid="625" pm="."><plain>Biophys. </plain></SENT>
<SENT sid="626" pm="."><plain>Acta 1852, 2292–2300. 10.1016/j.bbadis.2015.04.026<?supplied-pmid 25957554?>25957554 </plain></SENT>
</text></ref><ref id="B87"><text><SENT sid="627" pm="."><plain>NgoJ. </plain></SENT>
<SENT sid="628" pm="."><plain>K.DaviesK. </plain></SENT>
<SENT sid="629" pm="."><plain>J. (2007). Importance of the lon protease in mitochondrial maintenance and the significance of declining lon in aging. Ann. </plain></SENT>
<SENT sid="630" pm="."><plain>N. </plain></SENT>
<SENT sid="631" pm="."><plain>Y. </plain></SENT>
<SENT sid="632" pm="."><plain>Acad. </plain></SENT>
<SENT sid="633" pm="."><plain>Sci. 1119, 78–87. 10.1196/annals.1404.015<?supplied-pmid 18056957?>18056957 </plain></SENT>
</text></ref><ref id="B88"><text><SENT sid="634" pm="."><plain>NilssonE.YinD. (1997). Preparation of artificial ceroid/lipofuscin by UV-oxidation of subcellular organelles. Mech. </plain></SENT>
<SENT sid="635" pm="."><plain>Ageing Dev. 99, 61–78. 10.1016/S0047-6374(97)00091-2<?supplied-pmid 9430105?>9430105 </plain></SENT>
</text></ref><ref id="B89"><text><SENT sid="636" pm="."><plain>NitaD. </plain></SENT>
<SENT sid="637" pm="."><plain>A.MoleS. </plain></SENT>
<SENT sid="638" pm="."><plain>E.MinassianB. </plain></SENT>
<SENT sid="639" pm="."><plain>A. (2016). Neuronal ceroid lipofuscinoses. Epileptic Disord. 18, 73–88. 10.1684/epd.2016.0844<?supplied-pmid 27629553?>27629553 </plain></SENT>
</text></ref><ref id="B90"><text><SENT sid="640" pm="."><plain>OhgamiN.YajimaI.IidaM.LiX.OshinoR.KumasakaM. </plain></SENT>
<SENT sid="641" pm="."><plain>Y.. </plain></SENT>
<SENT sid="642" pm="."><plain>(2016). Manganese-mediated acceleration of age-related hearing loss in mice. Sci. </plain></SENT>
<SENT sid="643" pm="."><plain>Rep. 6:36306. 10.1038/srep36306<?supplied-pmid 27824154?>27824154 </plain></SENT>
</text></ref><ref id="B91"><text><SENT sid="644" pm="."><plain>OpalachK.RangarajuS.MadorskyI.LeeuwenburghC.NotterpekL. (2010). Lifelong calorie restriction alleviates age-related oxidative damage in peripheral nerves. Rejuvenation Res. 13, 65–74. 10.1089/rej.2009.0892<?supplied-pmid 20230280?>20230280 </plain></SENT>
</text></ref><ref id="B92"><text><SENT sid="645" pm="."><plain>OttisP.KoppeK.OniskoB.DyninI.ArzbergerT.KretzschmarH.. </plain></SENT>
<SENT sid="646" pm="."><plain>(2012). Human and rat brain lipofuscin proteome. Proteomics 12, 2445–2454. 10.1002/pmic.201100668<?supplied-pmid 22707227?>22707227 </plain></SENT>
</text></ref><ref id="B93"><text><SENT sid="647" pm="."><plain>PanX.De AragãoC. </plain></SENT>
<SENT sid="648" pm="."><plain>B. </plain></SENT>
<SENT sid="649" pm="."><plain>P.Velasco-MartinJ. </plain></SENT>
<SENT sid="650" pm="."><plain>P.PriestmanD. </plain></SENT>
<SENT sid="651" pm="."><plain>A.WuH. </plain></SENT>
<SENT sid="652" pm="."><plain>Y.TakahashiK.. </plain></SENT>
<SENT sid="653" pm="."><plain>(2017). Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides. FASEB J. 31, 3467–3483. 10.1096/fj.201601299R<?supplied-pmid 28442549?>28442549 </plain></SENT>
</text></ref><ref id="B94"><text><SENT sid="654" pm="."><plain>ParishC. </plain></SENT>
<SENT sid="655" pm="."><plain>A.HashimotoM.NakanishiK.DillonJ.SparrowJ. (1998). Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc. </plain></SENT>
<SENT sid="656" pm="."><plain>Natl. </plain></SENT>
<SENT sid="657" pm="."><plain>Acad. </plain></SENT>
<SENT sid="658" pm="."><plain>Sci. </plain></SENT>
<SENT sid="659" pm="."><plain>U.S.A. 95, 14609–14613. 10.1073/pnas.95.25.14609<?supplied-pmid 9843937?>9843937 </plain></SENT>
</text></ref><ref id="B95"><text><SENT sid="660" pm="."><plain>PearseA. </plain></SENT>
<SENT sid="661" pm="."><plain>G. </plain></SENT>
<SENT sid="662" pm="."><plain>E. (1985). Histochemistry. </plain></SENT>
<SENT sid="663" pm="."><plain>Theoretical and Applied. </plain></SENT>
<SENT sid="664" pm="."><plain>Analytical Technology, 4th Edn. London: Churchill Livingstone. </plain></SENT>
</text></ref><ref id="B96"><text><SENT sid="665" pm="."><plain>PetkauT. </plain></SENT>
<SENT sid="666" pm="."><plain>L.BlancoJ.LeavittB. </plain></SENT>
<SENT sid="667" pm="."><plain>R. (2017). Conditional loss of progranulin in neurons is not sufficient to cause neuronal ceroid lipofuscinosis-like neuropathology in mice. Neurobiol. </plain></SENT>
<SENT sid="668" pm="."><plain>Dis. 106, 14–22. 10.1016/j.nbd.2017.06.01228647554 </plain></SENT>
</text></ref><ref id="B97"><text><SENT sid="669" pm="."><plain>PetkauT. </plain></SENT>
<SENT sid="670" pm="."><plain>L.HillA.LeavittB. </plain></SENT>
<SENT sid="671" pm="."><plain>R. (2016). Core neuropathological abnormalities in progranulin-deficient mice are penetrant on multiple genetic backgrounds. Neuroscience 315, 175–195. 10.1016/j.neuroscience.2015.12.006<?supplied-pmid 26701296?>26701296 </plain></SENT>
</text></ref><ref id="B98"><text><SENT sid="672" pm="."><plain>PollreiszA.MessingerJ. </plain></SENT>
<SENT sid="673" pm="."><plain>D.SloanK. </plain></SENT>
<SENT sid="674" pm="."><plain>R.MittermuellerT. </plain></SENT>
<SENT sid="675" pm="."><plain>J.WeinhandlA. </plain></SENT>
<SENT sid="676" pm="."><plain>S.BensonE. </plain></SENT>
<SENT sid="677" pm="."><plain>K.. </plain></SENT>
<SENT sid="678" pm="."><plain>(2018). Visualizing melanosomes, lipofuscin, and melanolipofuscin in human retinal pigment epithelium using serial block face scanning electron microscopy. Exp. </plain></SENT>
<SENT sid="679" pm="."><plain>Eye Res. 166, 131–139. 10.1016/j.exer.2017.10.018<?supplied-pmid 29066281?>29066281 </plain></SENT>
</text></ref><ref id="B99"><text><SENT sid="680" pm="."><plain>PopovicD.VucicD.DikicI. (2014). Ubiquitination in disease pathogenesis and treatment. Nat. </plain></SENT>
<SENT sid="681" pm="."><plain>Med. 20, 1242–1253. 10.1038/nm.3739<?supplied-pmid 25375928?>25375928 </plain></SENT>
</text></ref><ref id="B100"><text><SENT sid="682" pm="."><plain>PortaE. </plain></SENT>
<SENT sid="683" pm="."><plain>A. (2002). Pigments in aging: an overview. Ann. </plain></SENT>
<SENT sid="684" pm="."><plain>N. </plain></SENT>
<SENT sid="685" pm="."><plain>Y. </plain></SENT>
<SENT sid="686" pm="."><plain>Acad. </plain></SENT>
<SENT sid="687" pm="."><plain>Sci. 959, 57–65. 10.1111/j.1749-6632.2002.tb02083.x<?supplied-pmid 11976186?>11976186 </plain></SENT>
</text></ref><ref id="B101"><text><SENT sid="688" pm="."><plain>PowellS. </plain></SENT>
<SENT sid="689" pm="."><plain>R.WangP.DivaldA.TeichbergS.HaridasV.McCloskeyT. </plain></SENT>
<SENT sid="690" pm="."><plain>W.. </plain></SENT>
<SENT sid="691" pm="."><plain>(2005). Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. Free Radic. </plain></SENT>
<SENT sid="692" pm="."><plain>Biol. </plain></SENT>
<SENT sid="693" pm="."><plain>Med. 38, 1093–1101. 10.1016/j.freeradbiomed.2005.01.003<?supplied-pmid 15780767?>15780767 </plain></SENT>
</text></ref><ref id="B102"><text><SENT sid="694" pm="."><plain>RangarajuS.HankinsD.MadorskyI.MadorskyE.LeeW. </plain></SENT>
<SENT sid="695" pm="."><plain>H.CarterC. </plain></SENT>
<SENT sid="696" pm="."><plain>S.. </plain></SENT>
<SENT sid="697" pm="."><plain>(2009). The molecular architecture of myelinated peripheral nerves is supported by calorie restriction with aging. Aging Cell 8, 178–191. 10.1111/j.1474-9726.2009.00460.x<?supplied-pmid 19239416?>19239416 </plain></SENT>
</text></ref><ref id="B103"><text><SENT sid="698" pm="."><plain>ReegS.GruneT. (2015). Protein oxidation in aging: does it play a role in aging progression? Antioxid. </plain></SENT>
<SENT sid="699" pm="."><plain>Redox Signal. 23, 239–255. 10.1089/ars.2014.6062<?supplied-pmid 25178482?>25178482 </plain></SENT>
</text></ref><ref id="B104"><text><SENT sid="700" pm="."><plain>Richter-LandsbergC.LeykJ. (2013). Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration. Acta Neuropathol. 126, 793–807. 10.1007/s00401-013-1158-x<?supplied-pmid 23912309?>23912309 </plain></SENT>
</text></ref><ref id="B105"><text><SENT sid="701" pm="."><plain>RigaD.RigaS.HalalauF.SchneiderF. (2006a). Brain lipopigment accumulation in normal and pathological aging. Ann. </plain></SENT>
<SENT sid="702" pm="."><plain>N. </plain></SENT>
<SENT sid="703" pm="."><plain>Y. </plain></SENT>
<SENT sid="704" pm="."><plain>Acad. </plain></SENT>
<SENT sid="705" pm="."><plain>Sci. 1067, 158–163. 10.1196/annals.1354.019<?supplied-pmid 16803981?>16803981 </plain></SENT>
</text></ref><ref id="B106"><text><SENT sid="706" pm="."><plain>RigaS.RigaD.SchneiderF.HalalauF. (2006b). Processing, lysis, and elimination of brain lipopigments in rejuvenation therapies. Ann. </plain></SENT>
<SENT sid="707" pm="."><plain>N. </plain></SENT>
<SENT sid="708" pm="."><plain>Y. </plain></SENT>
<SENT sid="709" pm="."><plain>Acad. </plain></SENT>
<SENT sid="710" pm="."><plain>Sci. 1067, 383–387. 10.1196/annals.1354.054<?supplied-pmid 16804015?>16804015 </plain></SENT>
</text></ref><ref id="B107"><text><SENT sid="711" pm="."><plain>RodgersK. </plain></SENT>
<SENT sid="712" pm="."><plain>J.FordJ. </plain></SENT>
<SENT sid="713" pm="."><plain>L.BrunkU. </plain></SENT>
<SENT sid="714" pm="."><plain>T. (2009). Heat shock proteins: keys to healthy ageing? Redox Rep. 14, 147–153. 10.1179/135100009X392593<?supplied-pmid 19695121?>19695121 </plain></SENT>
</text></ref><ref id="B108"><text><SENT sid="715" pm="."><plain>RodolfoC.CampelloS.CecconiF. (2018). Mitophagy in neurodegenerative diseases. Neurochem. </plain></SENT>
<SENT sid="716" pm="."><plain>Int. 117, 156–166. 10.1016/j.neuint.2017.08.004<?supplied-pmid 28797885?>28797885 </plain></SENT>
</text></ref><ref id="B109"><text><SENT sid="717" pm="."><plain>Rodríguez-MuelaN.KogaH.García-LedoL.de la VillaP.de la RosaE. </plain></SENT>
<SENT sid="718" pm="."><plain>J.CuervoA. </plain></SENT>
<SENT sid="719" pm="."><plain>M.. </plain></SENT>
<SENT sid="720" pm="."><plain>(2013). Balance between autophagic pathways preserves retinal homeostasis. Aging Cell 12, 478–488. 10.1111/acel.12072<?supplied-pmid 23521856?>23521856 </plain></SENT>
</text></ref><ref id="B110"><text><SENT sid="721" pm="."><plain>RossC. </plain></SENT>
<SENT sid="722" pm="."><plain>A.AylwardE. </plain></SENT>
<SENT sid="723" pm="."><plain>H.WildE. </plain></SENT>
<SENT sid="724" pm="."><plain>J.LangbehnD. </plain></SENT>
<SENT sid="725" pm="."><plain>R.LongJ. </plain></SENT>
<SENT sid="726" pm="."><plain>D.WarnerJ. </plain></SENT>
<SENT sid="727" pm="."><plain>H.. </plain></SENT>
<SENT sid="728" pm="."><plain>(2014). Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat. </plain></SENT>
<SENT sid="729" pm="."><plain>Rev. </plain></SENT>
<SENT sid="730" pm="."><plain>Neurol. 10, 204–216. 10.1038/nrneurol.2014.24<?supplied-pmid 24614516?>24614516 </plain></SENT>
</text></ref><ref id="B111"><text><SENT sid="731" pm="."><plain>RossC. </plain></SENT>
<SENT sid="732" pm="."><plain>A.PoirierM. </plain></SENT>
<SENT sid="733" pm="."><plain>A. (2005). Opinion: what is the role of protein aggregation in neurodegeneration? Nat. </plain></SENT>
<SENT sid="734" pm="."><plain>Rev. </plain></SENT>
<SENT sid="735" pm="."><plain>Mol. </plain></SENT>
<SENT sid="736" pm="."><plain>Cell Biol. 6, 891–898. 10.1038/nrm1742<?supplied-pmid 16167052?>16167052 </plain></SENT>
</text></ref><ref id="B112"><text><SENT sid="737" pm="."><plain>RyhänenT.HyttinenJ. </plain></SENT>
<SENT sid="738" pm="."><plain>M. </plain></SENT>
<SENT sid="739" pm="."><plain>T.KopitzJ.RillaK.KuusistoE.MannermaaE.. </plain></SENT>
<SENT sid="740" pm="."><plain>(2009). Crosstalk between Hsp70 molecular chaperone, lysosomes and proteasomes in autophagy-mediated proteolysis in human retinal pigment epithelial cells. J. Cell. </plain></SENT>
<SENT sid="742" pm="."><plain>Mol. </plain></SENT>
<SENT sid="743" pm="."><plain>Med. 13, 3616–3631. 10.1111/j.1582-4934.2008.00577.x<?supplied-pmid 19017362?>19017362 </plain></SENT>
</text></ref><ref id="B113"><text><SENT sid="744" pm="."><plain>SchwartsburdP. </plain></SENT>
<SENT sid="745" pm="."><plain>M. (1995). On the origin of heterogeneity of lipofuscin fluorophores and their possible interrelations. Gerontology 41(Suppl. </plain></SENT>
<SENT sid="746" pm="."><plain>2), 29–37. 10.1159/000213723<?supplied-pmid 8821319?>8821319 </plain></SENT>
</text></ref><ref id="B114"><text><SENT sid="747" pm="."><plain>SchwarzburdP. </plain></SENT>
<SENT sid="748" pm="."><plain>M.AslanidiK. </plain></SENT>
<SENT sid="749" pm="."><plain>B. (1991). Resistance of single tumor cells and their intracellular compartments to lipid peroxidation. Med. </plain></SENT>
<SENT sid="750" pm="."><plain>Oncol. </plain></SENT>
<SENT sid="751" pm="."><plain>Tumor Pharmacother. 8, 57–61. <?supplied-pmid 1749300?>1749300 </plain></SENT>
</text></ref><ref id="B115"><text><SENT sid="752" pm="."><plain>SeiberlichV.BorchertJ.ZhukarevaV.Richter-LandsbergC. (2013). Inhibition of protein deubiquitination by PR-619 activates the autophagic pathway in OLN-t40 oligodendroglial cells. Cell Biochem. </plain></SENT>
<SENT sid="753" pm="."><plain>Biophys. 67, 149–160. 10.1007/s12013-013-9622-8<?supplied-pmid 23686611?>23686611 </plain></SENT>
</text></ref><ref id="B116"><text><SENT sid="754" pm="."><plain>SiakotosA. </plain></SENT>
<SENT sid="755" pm="."><plain>N. (1974). Procedures for the isolation of brain lipopigments: ceroid and lipofuscin. Meth. </plain></SENT>
<SENT sid="756" pm="."><plain>Enzymol. 31, 478–485. 10.1016/0076-6879(74)31053-1<?supplied-pmid 4419292?>4419292 </plain></SENT>
</text></ref><ref id="B117"><text><SENT sid="757" pm="."><plain>SitteN.HuberM.GruneT.LadhoffA.DoeckeW. </plain></SENT>
<SENT sid="758" pm="."><plain>D.ZglinickiT. </plain></SENT>
<SENT sid="759" pm="."><plain>V.. </plain></SENT>
<SENT sid="760" pm="."><plain>(2000). Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J. 14, 1490–1498. 10.1096/fj.99-0843com<?supplied-pmid 10928983?>10928983 </plain></SENT>
</text></ref><ref id="B118"><text><SENT sid="761" pm="."><plain>SkoumalováA.HortJ. (2012). Blood markers of oxidative stress in Alzheimer's disease. J. Cell. </plain></SENT>
<SENT sid="763" pm="."><plain>Mol. </plain></SENT>
<SENT sid="764" pm="."><plain>Med. 16, 2291–2300. 10.1111/j.1582-4934.2012.01585.x<?supplied-pmid 22564475?>22564475 </plain></SENT>
</text></ref><ref id="B119"><text><SENT sid="765" pm="."><plain>SmithK. </plain></SENT>
<SENT sid="766" pm="."><plain>R.DamianoJ.FranceschettiS.CarpenterS.CanafogliaL.MorbinM.. </plain></SENT>
<SENT sid="767" pm="."><plain>(2012). Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am. </plain></SENT>
<SENT sid="768" pm="."><plain>J. </plain></SENT>
<SENT sid="769" pm="."><plain>Hum. </plain></SENT>
<SENT sid="770" pm="."><plain>Genet. 90, 1102–1107. 10.1016/j.ajhg.2012.04.021<?supplied-pmid 22608501?>22608501 </plain></SENT>
</text></ref><ref id="B120"><text><SENT sid="771" pm="."><plain>StewardC. </plain></SENT>
<SENT sid="772" pm="."><plain>G. (2003). Neurological aspects of osteopetrosis. Neuropathol. </plain></SENT>
<SENT sid="773" pm="."><plain>Appl. </plain></SENT>
<SENT sid="774" pm="."><plain>Neurobiol. 29, 87–97. 10.1046/j.1365-2990.2003.00474.x<?supplied-pmid 12662317?>12662317 </plain></SENT>
</text></ref><ref id="B121"><text><SENT sid="775" pm="."><plain>SugayaA.SugimiotoH.MogiN.TsujigamiH.DeguchiS. (2004). Experimental diabetes accelerates accumulation of fluorescent pigments in rat trigeminal neurons. Brain Res. 999, 132–134. 10.1016/j.brainres.2003.11.033<?supplied-pmid 14746930?>14746930 </plain></SENT>
</text></ref><ref id="B122"><text><SENT sid="776" pm="."><plain>TangC. </plain></SENT>
<SENT sid="777" pm="."><plain>H.LeeJ. </plain></SENT>
<SENT sid="778" pm="."><plain>W.GalvezM. </plain></SENT>
<SENT sid="779" pm="."><plain>G.RobillardL.MoleS. </plain></SENT>
<SENT sid="780" pm="."><plain>E.ChapmanH. </plain></SENT>
<SENT sid="781" pm="."><plain>A. (2006). Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease. Mol. </plain></SENT>
<SENT sid="782" pm="."><plain>Cell. </plain></SENT>
<SENT sid="783" pm="."><plain>Biol. 26, 2309–2316. 10.1128/MCB.26.6.2309-2316.2006<?supplied-pmid 16508006?>16508006 </plain></SENT>
</text></ref><ref id="B123"><text><SENT sid="784" pm="."><plain>TauboldR. </plain></SENT>
<SENT sid="785" pm="."><plain>D.SiakotosA. </plain></SENT>
<SENT sid="786" pm="."><plain>N.PerkinsE. </plain></SENT>
<SENT sid="787" pm="."><plain>G. (1975). Studies on chemical nature of lipofuscin (age pigment) isolated from normal human brain. Lipids 10, 383–390. 10.1007/BF025324411143025 </plain></SENT>
</text></ref><ref id="B124"><text><SENT sid="788" pm="."><plain>Tellez-NagelI.JohnsonA. </plain></SENT>
<SENT sid="789" pm="."><plain>B.TerryR. </plain></SENT>
<SENT sid="790" pm="."><plain>D. (1974). Studies on brain biopsies of patients with Huntington's chorea. J. Neuropathol. </plain></SENT>
<SENT sid="792" pm="."><plain>Exp. </plain></SENT>
<SENT sid="793" pm="."><plain>Neurol. 33, 308–332. <?supplied-pmid 4150800?>4150800 </plain></SENT>
</text></ref><ref id="B125"><text><SENT sid="794" pm="."><plain>TermanA. (2001). Garbage catastrophe theory of aging: imperfect removal of oxidative damage? Redox Rep. </plain></SENT>
<SENT sid="795" pm="."><plain>Commun. </plain></SENT>
<SENT sid="796" pm="."><plain>Free Radic. </plain></SENT>
<SENT sid="797" pm="."><plain>Res. 6, 15–26. 10.1179/135100001101535996<?supplied-pmid 11333111?>11333111 </plain></SENT>
</text></ref><ref id="B126"><text><SENT sid="798" pm="."><plain>TermanA.BrunkU. </plain></SENT>
<SENT sid="799" pm="."><plain>T. (1998). Lipofuscin: Mechanisms of formation and increase with age. APMIS 106, 265–276. 10.1111/j.1699-0463.1998.tb01346.x<?supplied-pmid 9531959?>9531959 </plain></SENT>
</text></ref><ref id="B127"><text><SENT sid="800" pm="."><plain>TermanA.BrunkU. </plain></SENT>
<SENT sid="801" pm="."><plain>T. (2004). Lipofuscin. Int. </plain></SENT>
<SENT sid="802" pm="."><plain>J. </plain></SENT>
<SENT sid="803" pm="."><plain>Biochem. </plain></SENT>
<SENT sid="804" pm="."><plain>Cell Biol. 36, 1400–1404. 10.1016/j.biocel.2003.08.009<?supplied-pmid 15147719?>15147719 </plain></SENT>
</text></ref><ref id="B128"><text><SENT sid="805" pm="."><plain>TermanA.BrunkU. </plain></SENT>
<SENT sid="806" pm="."><plain>T. (2005). The aging myocardium: roles of mitochondrial damage and lysosomal degradation. Heart Lung Circ. 14, 107–114. 10.1016/j.hlc.2004.12.023<?supplied-pmid 16352265?>16352265 </plain></SENT>
</text></ref><ref id="B129"><text><SENT sid="807" pm="."><plain>TermanA.KurzT.NavratilM.ArriagaE. </plain></SENT>
<SENT sid="808" pm="."><plain>A.BrunkU. </plain></SENT>
<SENT sid="809" pm="."><plain>T. (2010). Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial–lysosomal axis theory of aging. Antioxid. </plain></SENT>
<SENT sid="810" pm="."><plain>Redox Signal. 12, 503–535. 10.1089/ars.2009.2598<?supplied-pmid 19650712?>19650712 </plain></SENT>
</text></ref><ref id="B130"><text><SENT sid="811" pm="."><plain>TerzibasiE.LefrançoisC.DomeniciP.HartmannN.GrafM.CellerinoA. (2009). Effects of dietary restriction on mortality and age-related phenotypes in the short-lived fish Nothobranchius furzeri. Aging Cell 8, 88–99. 10.1111/j.1474-9726.2009.00455.x<?supplied-pmid 19302373?>19302373 </plain></SENT>
</text></ref><ref id="B131"><text><SENT sid="812" pm="."><plain>TokutakeS.NagaseH.MorisakiS.OyanagiS. (1995). Aluminium detected in senile plaques and neurofibrillary tangles is contained in lipofuscin granules with silicon, probably as aluminosilicate. Neurosci. </plain></SENT>
<SENT sid="813" pm="."><plain>Lett. 185, 99–102. 10.1016/0304-3940(94)11234-A<?supplied-pmid 7746513?>7746513 </plain></SENT>
</text></ref><ref id="B132"><text><SENT sid="814" pm="."><plain>TuoJ.BojanowskiC. </plain></SENT>
<SENT sid="815" pm="."><plain>M.ZhouM.ShenD.RossR. </plain></SENT>
<SENT sid="816" pm="."><plain>J.RosenbergK. </plain></SENT>
<SENT sid="817" pm="."><plain>I.. </plain></SENT>
<SENT sid="818" pm="."><plain>(2007). Murine Ccl2/Cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest. </plain></SENT>
<SENT sid="819" pm="."><plain>Ophthalmol. </plain></SENT>
<SENT sid="820" pm="."><plain>Vis. </plain></SENT>
<SENT sid="821" pm="."><plain>Sci. 48, 3827–3836. 10.1167/iovs.07-0051<?supplied-pmid 17652758?>17652758 </plain></SENT>
</text></ref><ref id="B133"><text><SENT sid="822" pm="."><plain>Vidal-DonetJ. </plain></SENT>
<SENT sid="823" pm="."><plain>M.Cárcel-TrullolsJ.CasanovaB.AguadoC.KnechtE. (2013). Alterations in ROS activity and lysosomal pH account for distinct patterns of macroautophagy in LINCL and JNCL fibroblasts. PLoS ONE 8:e55526. 10.1371/journal.pone.0055526<?supplied-pmid 23408996?>23408996 </plain></SENT>
</text></ref><ref id="B134"><text><SENT sid="824" pm="."><plain>VolchegorskiiI. </plain></SENT>
<SENT sid="825" pm="."><plain>A.RassokhinaL. </plain></SENT>
<SENT sid="826" pm="."><plain>M.MiroshnichenkoI. </plain></SENT>
<SENT sid="827" pm="."><plain>Y. (2013). Dynamics of lipid peroxidation-antioxidant defense system during alloxan diabetes in rats. Bull. </plain></SENT>
<SENT sid="828" pm="."><plain>Exp. </plain></SENT>
<SENT sid="829" pm="."><plain>Biol. </plain></SENT>
<SENT sid="830" pm="."><plain>Med. 155, 26–29. 10.1007/s10517-013-2071-y<?supplied-pmid 23667864?>23667864 </plain></SENT>
</text></ref><ref id="B135"><text><SENT sid="831" pm="."><plain>VonsattelJ. </plain></SENT>
<SENT sid="832" pm="."><plain>P. </plain></SENT>
<SENT sid="833" pm="."><plain>G.DifigliaM. (1998). Huntington Disease. J. Neuropathol. </plain></SENT>
<SENT sid="835" pm="."><plain>Exp. </plain></SENT>
<SENT sid="836" pm="."><plain>Neurol. 57, 369–384. 10.1097/00005072-199805000-00001<?supplied-pmid 9596408?>9596408 </plain></SENT>
</text></ref><ref id="B136"><text><SENT sid="837" pm="."><plain>WakabayashiK.KobayashiH.KawasakiS.KondoH.TakahashiH. (2001). Autosomal recessive spastic paraplegia with hypoplastic corpus callosum, multisystem degeneration and ubiquitinated eosinophilic granules. Acta Neuropathol. 101, 69–73. 10.1007/s004010000255<?supplied-pmid 11194944?>11194944 </plain></SENT>
</text></ref><ref id="B137"><text><SENT sid="838" pm="."><plain>WarburtonS.DavisW. </plain></SENT>
<SENT sid="839" pm="."><plain>E.SouthwickK.XinH.WoolleyA. </plain></SENT>
<SENT sid="840" pm="."><plain>T.BurtonG. </plain></SENT>
<SENT sid="841" pm="."><plain>F.. </plain></SENT>
<SENT sid="842" pm="."><plain>(2007). Proteomic and phototoxic characterization of melanolipofuscin: correlation to disease and model for its origin. Mol. </plain></SENT>
<SENT sid="843" pm="."><plain>Vis. 13, 318–329. 10.1007/0-387-32442-9_11<?supplied-pmid 17392682?>17392682 </plain></SENT>
</text></ref><ref id="B138"><text><SENT sid="844" pm="."><plain>WardM. </plain></SENT>
<SENT sid="845" pm="."><plain>E.ChenR.HuangH. </plain></SENT>
<SENT sid="846" pm="."><plain>Y.LudwigC.TelpoukhovskaiaM.TaubesA.. </plain></SENT>
<SENT sid="847" pm="."><plain>(2017). Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis. Sci. </plain></SENT>
<SENT sid="848" pm="."><plain>Transl. </plain></SENT>
<SENT sid="849" pm="."><plain>Med. 9:eaah5642. 10.1126/scitranslmed.aah5642<?supplied-pmid 28404863?>28404863 </plain></SENT>
</text></ref><ref id="B139"><text><SENT sid="850" pm="."><plain>WeinertS.JabsS.SupanchartC.SchweizerM.GimberN.RichterM.. </plain></SENT>
<SENT sid="851" pm="."><plain>(2010). Lysosomal pathology and osteopetrosis upon loss of H+-driven lysosomal Cl- accumulation. Science 328, 1401–1403. 10.1126/science.1188072<?supplied-pmid 20430974?>20430974 </plain></SENT>
</text></ref><ref id="B140"><text><SENT sid="852" pm="."><plain>WellingsT. </plain></SENT>
<SENT sid="853" pm="."><plain>P.BrichtaA. </plain></SENT>
<SENT sid="854" pm="."><plain>M.LimR. (2017). Altered neurofilament protein expression in the lateral vestibular nucleus in Parkinson's disease. Exp. </plain></SENT>
<SENT sid="855" pm="."><plain>Brain Res. 235, 3695–3708. 10.1007/s00221-017-5092-3<?supplied-pmid 28929183?>28929183 </plain></SENT>
</text></ref><ref id="B141"><text><SENT sid="856" pm="."><plain>WenischS.HildA.BitschI.LeiserR.HummelG. (1997). Ultrastructure of rat Purkinje neurons after chronic ethanol consumption and prolonged abstinence. Anat. </plain></SENT>
<SENT sid="857" pm="."><plain>Histol. </plain></SENT>
<SENT sid="858" pm="."><plain>Embryol. 26, 93–98. 10.1111/j.1439-0264.1997.tb00106.x<?supplied-pmid 9210781?>9210781 </plain></SENT>
</text></ref><ref id="B142"><text><SENT sid="859" pm="."><plain>WilliamsR. </plain></SENT>
<SENT sid="860" pm="."><plain>E.AdamsH. </plain></SENT>
<SENT sid="861" pm="."><plain>R.BlohmM.Cohen-PfefferJ. </plain></SENT>
<SENT sid="862" pm="."><plain>L.ReyesE.de losDeneckeJ.. </plain></SENT>
<SENT sid="863" pm="."><plain>(2017). Management Strategies for CLN2 Disease. Pediatr. </plain></SENT>
<SENT sid="864" pm="."><plain>Neurol. 69, 102–112. 10.1016/j.pediatrneurol.2017.01.034<?supplied-pmid 28335910?>28335910 </plain></SENT>
</text></ref><ref id="B143"><text><SENT sid="865" pm="."><plain>YamasakiR.ZhangJ.KoshiishiI.Sastradipura SuniartiD. </plain></SENT>
<SENT sid="866" pm="."><plain>F.WuZ.PetersC.. </plain></SENT>
<SENT sid="867" pm="."><plain>(2007). Involvement of lysosomal storage-induced p38 MAP kinase activation in the overproduction of nitric oxide by microglia in cathepsin D-deficient mice. Mol. </plain></SENT>
<SENT sid="868" pm="."><plain>Cell. </plain></SENT>
<SENT sid="869" pm="."><plain>Neurosci. 35, 573–584. 10.1016/j.mcn.2007.05.002<?supplied-pmid 17570679?>17570679 </plain></SENT>
</text></ref><ref id="B144"><text><SENT sid="870" pm="."><plain>YoshikawaM.UchidaS.EzakiJ.RaiT.HayamaA.KobayashiK.. </plain></SENT>
<SENT sid="871" pm="."><plain>(2002). CLC-3 deficiency leads to phenotypes similar to human neuronal ceroid lipofuscinosis. Genes Cells Devoted Mol. </plain></SENT>
<SENT sid="872" pm="."><plain>Cell. </plain></SENT>
<SENT sid="873" pm="."><plain>Mech. 7, 597–605. 10.1046/j.1365-2443.2002.00539.x<?supplied-pmid 12059962?>12059962 </plain></SENT>
</text></ref><ref id="B145"><text><SENT sid="874" pm="."><plain>ZhaoL.SpassievaS. </plain></SENT>
<SENT sid="875" pm="."><plain>D.JuciusT. </plain></SENT>
<SENT sid="876" pm="."><plain>J.ShultzL. </plain></SENT>
<SENT sid="877" pm="."><plain>D.ShickH. </plain></SENT>
<SENT sid="878" pm="."><plain>E.MacklinW. </plain></SENT>
<SENT sid="879" pm="."><plain>B.. </plain></SENT>
<SENT sid="880" pm="."><plain>(2011). A deficiency of ceramide biosynthesis causes cerebellar purkinje cell neurodegeneration and lipofuscin accumulation. PLoS Genet. 7:e1002063. 10.1371/journal.pgen.1002063<?supplied-pmid 21625621?>21625621 </plain></SENT>
</text></ref><ref id="B146"><text><SENT sid="881" pm="."><plain>ZhengS.ClaboughE. </plain></SENT>
<SENT sid="882" pm="."><plain>B. </plain></SENT>
<SENT sid="883" pm="."><plain>D.SarkarS.FutterM.RubinszteinD. </plain></SENT>
<SENT sid="884" pm="."><plain>C.ZeitlinS. </plain></SENT>
<SENT sid="885" pm="."><plain>O. (2010). Deletion of the Huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice. PLoS Genet. 6:e1000838. 10.1371/journal.pgen.1000838<?supplied-pmid 20140187?>20140187 </plain></SENT>
</text></ref><ref id="B147"><text><SENT sid="886" pm="."><plain>ZhouX.SunL.BradyO. </plain></SENT>
<SENT sid="887" pm="."><plain>A.MurphyK. </plain></SENT>
<SENT sid="888" pm="."><plain>A.HuF. (2017). Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency. Acta Neuropathol. </plain></SENT>
<SENT sid="889" pm="."><plain>Commun. 5:9. 10.1186/s40478-017-0412-1<?supplied-pmid 28126008?>28126008 </plain></SENT>
</text></ref><ref id="B148"><text><SENT sid="890" pm="."><plain>ZhuY.FenikP.ZhanG.XinR.VeaseyS. </plain></SENT>
<SENT sid="891" pm="."><plain>C. (2015). Degeneration in arousal neurons in chronic sleep disruption modeling sleep apnea. Front. </plain></SENT>
<SENT sid="892" pm="."><plain>Neurol. 6:109. 10.3389/fneur.2015.00109<?supplied-pmid 26074865?>26074865 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
